UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended
OR
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number
(Exact Name of Registrant as Specified in its Charter)
|
|
|
(State or other jurisdiction of Incorporation or Organization) |
|
(I.R.S. Employer Identification Number) |
|
|
|
250 Greenwich Street, 49th Floor |
|
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
|
|
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
☒ |
Accelerated filer |
☐ |
Non-accelerated filer |
☐ |
Smaller reporting company |
|
|
|
Emerging growth company |
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
As of April 20, 2021, there were
FOR THE QUARTER ENDED MARCH 31, 2021
TABLE OF CONTENTS
|
|
|
|
Page |
|
|
|
|
|
Item 1. |
|
|
4 |
|
Item 2. |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|
20 |
Item 3. |
|
|
36 |
|
Item 4. |
|
|
37 |
|
|
|
|
|
|
|
|
|
|
|
Item 1. |
|
|
38 |
|
Item 1A. |
|
|
38 |
|
Item 2. |
|
|
38 |
|
Item 6. |
|
|
39 |
2
AVAILABLE INFORMATION
Our corporate headquarters is located at 7 World Trade Center, 250 Greenwich Street, 49th Floor, New York, New York, 10007, and our telephone number is (212) 804-3900. We maintain a website on the internet at www.msci.com. The contents of our website are not a part of or incorporated by reference in this Quarterly Report on Form 10-Q.
We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements and other information that we file electronically with the SEC at www.sec.gov. We also make available free of charge, on or through our website, these reports, proxy statements and other information as soon as reasonably practicable following the time they are electronically filed with or furnished to the SEC. To access these, click on the “SEC Filings” link found on our Investor Relations homepage (http://ir.msci.com).
We also use our Investor Relations homepage, Corporate Responsibility homepage and corporate Twitter account (@MSCI_Inc) as channels of distribution of Company information. The information we post through these channels may be deemed material.
Accordingly, investors should monitor these channels, in addition to following our press releases, SEC filings and public conference calls and webcasts. In addition, you may automatically receive email alerts and other information about us when you enroll your email address by visiting the “Email Alert Subscription” section of our Investor Relations homepage at http://ir.msci.com/alerts.cfm. The contents of our website, including our Investor Relations homepage, Corporate Responsibility homepage and social media channels are not, however, a part of or incorporated by reference in this Quarterly Report on Form 10-Q.
FORWARD-LOOKING STATEMENTS
We have included in this Quarterly Report on Form 10-Q, and from time to time may make in our public filings, press releases or other public statements, certain statements that constitute forward-looking statements. In addition, our management may make forward-looking statements to analysts, investors, representatives of the media and others. These forward-looking statements are not historical facts and represent only MSCI’s beliefs regarding future events, many of which, by their nature, are inherently uncertain and beyond our control.
In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or “continue,” or the negative of these terms or other comparable terminology. Statements concerning our financial position, business strategy and plans or objectives for future operations are forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control and that could materially affect our actual results, levels of activity, performance or achievements. Such risks and uncertainties include those set forth under “Risk Factors” in Part I, Item 1A of the 2020 Annual Report on Form 10-K filed with the SEC on February 12, 2021. Other factors that could materially affect actual results, levels of activity, performance or achievements can be found in quarterly reports on Form 10-Q and current reports on Form 8-K filed or furnished with the SEC. The forward-looking statements in this report speak only as of the time they are made and do not necessarily reflect our outlook at any other point in time. We undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or for any other reason. Therefore, readers should carefully review the risk factors set forth in other reports or documents we file from time to time with the Securities and Exchange Commission (the “SEC”).
3
PART I – FINANCIAL INFORMATION
Item 1. |
Financial Statements |
MSCI INC.
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION
(in thousands, except per share and share data)
|
|
As of |
|
|||||
|
|
March 31, |
|
|
December 31, |
|
||
|
|
2021 |
|
|
2020 |
|
||
|
|
(unaudited) |
|
|||||
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
|
|
|
$ |
|
|
Accounts receivable, net of allowances |
|
|
|
|
|
|
|
|
Prepaid income taxes |
|
|
|
|
|
|
|
|
Prepaid and other assets |
|
|
|
|
|
|
|
|
Total current assets |
|
|
|
|
|
|
|
|
Property, equipment and leasehold improvements, net |
|
|
|
|
|
|
|
|
Right of use assets |
|
|
|
|
|
|
|
|
Goodwill |
|
|
|
|
|
|
|
|
Intangible assets, net |
|
|
|
|
|
|
|
|
Equity method investment |
|
|
|
|
|
|
|
|
Deferred tax assets |
|
|
|
|
|
|
|
|
Other non-current assets |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
|
|
|
$ |
|
|
Income taxes payable |
|
|
|
|
|
|
|
|
Accrued compensation and related benefits |
|
|
|
|
|
|
|
|
Current maturities of long-term debt |
|
|
|
|
|
|
— |
|
Other accrued liabilities |
|
|
|
|
|
|
|
|
Deferred revenue |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
|
|
|
|
|
|
Long-term debt |
|
|
|
|
|
|
|
|
Long-term operating lease liabilities |
|
|
|
|
|
|
|
|
Deferred tax liabilities |
|
|
|
|
|
|
|
|
Other non-current liabilities |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitments and Contingencies (see Note 7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' equity (deficit): |
|
|
|
|
|
|
|
|
Preferred stock (par value $ |
|
|
|
|
|
|
|
|
Common stock (par value $ and shares outstanding at March 31, 2021 and December 31, 2020, respectively) |
|
|
|
|
|
|
|
|
Treasury shares, at cost ( and December 31, 2020, respectively) |
|
|
( |
) |
|
|
( |
) |
Additional paid in capital |
|
|
|
|
|
|
|
|
Retained earnings |
|
|
|
|
|
|
|
|
Accumulated other comprehensive loss |
|
|
( |
) |
|
|
( |
) |
Total shareholders' equity (deficit) |
|
|
( |
) |
|
|
( |
) |
Total liabilities and shareholders' equity (deficit) |
|
$ |
|
|
|
$ |
|
|
See Notes to Condensed Consolidated Financial Statements (Unaudited)
4
MSCI INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share data)
|
|
Three Months Ended |
|
|
|||||
|
|
March 31, |
|
|
|||||
|
|
2021 |
|
|
2020 |
|
|
||
|
|
(unaudited) |
|||||||
Operating revenues |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
Cost of revenues |
|
|
|
|
|
|
|
|
|
Selling and marketing |
|
|
|
|
|
|
|
|
|
Research and development |
|
|
|
|
|
|
|
|
|
General and administrative |
|
|
|
|
|
|
|
|
|
Amortization of intangible assets |
|
|
|
|
|
|
|
|
|
Depreciation and amortization of property, equipment and leasehold improvements |
|
|
|
|
|
|
|
|
|
Total operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
( |
) |
|
|
( |
) |
|
Interest expense |
|
|
|
|
|
|
|
|
|
Other expense (income) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expense (income), net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income taxes |
|
|
|
|
|
|
|
|
|
Provision for income taxes |
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per basic common share |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per diluted common share |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding used in computing earnings per share |
|
|
|
|
|
|
|
|
|
Basic |
|
|
|
|
|
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
|
See Notes to Condensed Consolidated Financial Statements (Unaudited)
5
MSCI INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)
|
|
Three Months Ended |
|
|
|||||
|
|
March 31, |
|
|
|||||
|
|
2021 |
|
|
2020 |
|
|
||
|
|
(unaudited) |
|||||||
Net income |
|
$ |
|
|
|
$ |
|
|
|
Other comprehensive (loss) income: |
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
|
( |
) |
|
|
( |
) |
|
Income tax effect |
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments, net |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
Pension and other post-retirement adjustments |
|
|
|
|
|
|
|
|
|
Income tax effect |
|
|
( |
) |
|
|
( |
) |
|
Pension and other post-retirement adjustments, net |
|
|
|
|
|
|
|
|
|
Other comprehensive (loss) income, net of tax |
|
|
( |
) |
|
|
( |
) |
|
Comprehensive income |
|
$ |
|
|
|
$ |
|
|
|
See Notes to Condensed Consolidated Financial Statements (Unaudited)
6
MSCI INC.
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (DEFICIT)
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional |
|
|
|
|
|
|
Other |
|
|
|
|
|
||
|
|
Common |
|
|
Treasury |
|
|
Paid in |
|
|
Retained |
|
|
Comprehensive |
|
|
|
|
|
|||||
|
|
Stock |
|
|
Stock |
|
|
Capital |
|
|
Earnings |
|
|
Income (Loss) |
|
|
Total |
|
||||||
|
|
(unaudited) |
|
|||||||||||||||||||||
Balance at December 31, 2020 |
|
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared ($ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
( |
) |
Dividends paid in shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss), net of tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
Common stock issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares withheld for tax withholding and exercises |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
Compensation payable in common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock repurchased and held in treasury |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
Common stock issued to Directors and (held in)/released from treasury |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
Balance at March 31, 2021 |
|
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2019 |
|
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative-effect adjustment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared ($ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
( |
) |
Dividends paid in shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss), net of tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
Common stock issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares withheld for tax withholding |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
Compensation payable in common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock repurchased and held in treasury |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
Common stock issued to Directors and (held in)/released from treasury |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
Balance at March 31, 2020 |
|
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Notes to Condensed Consolidated Financial Statements (Unaudited)
7
MSCI INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
|
|
2021 |
|
|
2020 |
|
||
|
|
(unaudited) |
|
|||||
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Net income |
|
$ |
|
|
|
$ |
|
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
Amortization of intangible assets |
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
|
|
|
|
|
|
Depreciation and amortization of property, equipment and leasehold improvements |
|
|
|
|
|
|
|
|
Amortization of right of use assets |
|
|
|
|
|
|
|
|
Amortization of debt origination fees |
|
|
|
|
|
|
|
|
Loss on extinguishment of debt |
|
|
— |
|
|
|
|
|
Deferred taxes |
|
|
|
|
|
|
( |
) |
Other adjustments |
|
|
|
|
|
|
|
|
Changes in assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
|
|
|
|
|
|
Prepaid income taxes |
|
|
|
|
|
|
|
|
Prepaid and other assets |
|
|
|
|
|
|
|
|
Accounts payable |
|
|
( |
) |
|
|
( |
) |
Accrued compensation and related benefits |
|
|
( |
) |
|
|
( |
) |
Income taxes payable |
|
|
|
|
|
|
|
|
Other accrued liabilities |
|
|
|
|
|
|
( |
) |
Deferred revenue |
|
|
( |
) |
|
|
|
|
Long-term operating lease liabilities |
|
|
( |
) |
|
|
( |
) |
Other |
|
|
( |
) |
|
|
|
|
Net cash provided by operating activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
Acquisition of equity method investment |
|
|
— |
|
|
|
( |
) |
Capitalized software development costs |
|
|
( |
) |
|
|
( |
) |
Capital expenditures |
|
|
( |
) |
|
|
( |
) |
Net cash used in investing activities |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
|
|
|
Proceeds from borrowings, inclusive of premium |
|
|
|
|
|
|
|
|
Repayment of borrowings |
|
|
— |
|
|
|
( |
) |
Repurchase of common stock held in treasury |
|
|
( |
) |
|
|
( |
) |
Payment of dividends |
|
|
( |
) |
|
|
( |
) |
Payment of debt issuance costs in connection with debt |
|
|
( |
) |
|
|
( |
) |
Net cash provided by (used in) financing activities |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash |
|
|
|
|
|
|
( |
) |
Cash and cash equivalent, beginning of period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalent, end of period |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure of cash flow information: |
|
|
|
|
|
|
|
|
Cash paid for interest |
|
$ |
|
|
|
$ |
|
|
Cash paid for income taxes, net of refunds received |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure of non-cash investing activities |
|
|
|
|
|
|
|
|
Property, equipment and leasehold improvements in other accrued liabilities |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure of non-cash financing activities |
|
|
|
|
|
|
|
|
Cash dividends declared, but not yet paid |
|
$ |
|
|
|
$ |
|
|
See Notes to Condensed Consolidated Financial Statements (Unaudited)
8
MSCI INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. INTRODUCTION AND BASIS OF PRESENTATION
MSCI Inc., together with its wholly owned subsidiaries (the “Company” or “MSCI”) provides critical decision support tools and services that bring greater transparency to the global financial markets. MSCI’s tools and services include indexes; portfolio construction tools and risk-management services; environmental, social and governance (“ESG”) and climate solutions; and real estate benchmarks, return analytics services and market insights; much of which can be accessed by clients through multiple channels and platforms.
Basis of Presentation and Use of Estimates
These unaudited condensed consolidated financial statements include the accounts of MSCI and its wholly owned subsidiaries and include all adjustments of a normal, recurring nature necessary to state fairly the financial condition as of March 31, 2021 and December 31, 2020, the results of operations, comprehensive income and shareholders’ equity (deficit) for the three months ended March 31, 2021 and 2020 and cash flows for the three months ended March 31, 2021 and 2020. The unaudited condensed consolidated statement of financial condition and related financial statement information as of December 31, 2020 have been derived from the 2020 audited consolidated financial statements but do not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in MSCI’s Annual Report on Form 10-K for the year ended December 31, 2020. The results of operations for interim periods are not necessarily indicative of results for the entire year.
The Company’s unaudited condensed consolidated financial statements are prepared in accordance with GAAP. These accounting principles require the Company to make certain estimates and judgments that can affect the reported amounts of assets and liabilities as of the date of the unaudited condensed consolidated financial statements, as well as the reported amounts of operating revenues and expenses during the periods presented. Significant estimates and assumptions made by management include the deferral and recognition of revenue, research and development and software capitalization, assessment of impairment of long-lived assets, accrued compensation, income taxes, incremental borrowing rates and other matters that affect the unaudited condensed consolidated financial statements and related disclosures. The Company believes that estimates used in the preparation of these unaudited condensed consolidated financial statements are reasonable; however, actual results could differ materially from these estimates. Intercompany balances and transactions are eliminated in consolidation.
Certain prior period amounts have been reclassified to conform to the current period presentation. Effective January 1, 2021, the ESG and Climate operating segment is being presented as a separate reportable segment. The operating segments of Real Estate and The Burgiss Group, LLC (“Burgiss”) do not individually meet the segment reporting thresholds and have been combined and presented as part of the All Other – Private Assets reportable segment. The Company’s ownership interest in Burgiss, a global provider of investment decision tools for private capital, is classified as an equity-method investment. Therefore, the All Other – Private Assets segment does not include the Company’s proportionate share of operating revenues and Adjusted EBITDA related to Burgiss. The Company’s proportionate share of the income or loss from its equity-method investment in Burgiss is not a component of Adjusted EBITDA as it is reported as a component of other (expense) income, net.
Concentrations
For the three months ended March 31, 2021 and 2020, BlackRock, Inc. accounted for
Allowance for Credit Losses on Accounts Receivable
Following the adoption of Accounting Standards Update No. 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” effective beginning January 1, 2020, the Company records an allowance on customer accounts at the time of billing based on the estimated amount of the billing that will not be collected.
9
Changes in the allowance for credit losses on doubtful accounts receivable from December 31, 2019 to March 31, 2021 were as follows:
|
|
Amount |
|
|
|
|
(in thousands) |
|
|
Balance as of December 31, 2019 |
|
$ |
|
|
Addition (reduction) to credit loss expense |
|
|
|
|
Write-offs, net of recoveries |
|
|
( |
) |
Balance as of December 31, 2020 |
|
$ |
|
|
Addition (reduction) to credit loss expense |
|
|
|
|
Adjustments and write-offs, net of recoveries |
|
|
( |
) |
Balance as of March 31, 2021 |
|
$ |
|
|
2. RECENT ACCOUNTING STANDARDS UPDATES
There are no pending accounting standards updates that are currently expected to have a material impact on the Company.
3. REVENUE RECOGNITION
MSCI’s revenues are characterized by product type, which broadly reflects the nature of how they are recognized. The Company’s revenue types are recurring subscription, asset-based fees and non-recurring revenues. The Company also reports revenues by segment.
The tables that follow present the disaggregated revenues for the periods indicated:
|
|
For the Three Months ended March 31, 2021 |
|
|||||||||||||||||
|
|
Segments |
|
|
|
|
|
|||||||||||||
(in thousands) |
|
Index |
|
|
Analytics |
|
|
ESG and Climate |
|
|
All Other - Private Assets |
|
|
Total |
|
|||||
Revenue Types |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recurring subscriptions |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Asset-based fees |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
Non-recurring |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
|
For the Three Months ended March 31, 2020 |
|
|||||||||||||||||
|
|
Segments |
|
|
|
|
|
|||||||||||||
(in thousands) |
|
Index |
|
|
Analytics |
|
|
ESG and Climate |
|
|
All Other - Private Assets |
|
|
Total |
|
|||||
Revenue Types |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recurring subscriptions |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Asset-based fees |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
Non-recurring |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
The tables that follow present the change in accounts receivable and in deferred revenue between the dates indicated:
|
|
Accounts receivable |
|
|
Deferred revenue |
|
||
|
|
(in thousands) |
|
|||||
Opening (12/31/2020) |
|
$ |
|
|
|
$ |
|
|
Closing (03/31/2021) |
|
|
|
|
|
|
|
|
Increase/(decrease) |
|
$ |
( |
) |
|
$ |
( |
) |
|
|
Accounts receivable |
|
|
Deferred revenue |
|
||
|
|
(in thousands) |
|
|||||
Opening (12/31/2019) |
|
$ |
|
|
|
$ |
|
|
Closing (03/31/2020) |
|
|
|
|
|
|
|
|
Increase/(decrease) |
|
$ |
( |
) |
|
$ |
( |
) |
10
The amounts of revenue recognized in the periods that were included in the opening current deferred revenue, which reflects contract liability amounts, were $
|
|
As of |
|
|
|
|
March 31, |
|
|
|
|
2021 |
|
|
|
|
(in thousands) |
|
|
First |
|
$ |
|
|
Second |
|
|
|
|
Third |
|
|
|
|
Periods |
|
|
|
|
Total |
|
$ |
|
|
4. EARNINGS PER COMMON SHARE
Basic earnings per share (“EPS”) is computed by dividing net income by the weighted average number of common shares outstanding during the period. Common shares outstanding include common stock and vested restricted stock unit awards where recipients have satisfied the explicit vesting terms. Diluted EPS reflects the assumed conversion of all dilutive securities.
The following table presents the computation of basic and diluted EPS:
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
|
|
2021 |
|
|
2020 |
|
||
(in thousands, except per share data) |
|
|
|
|
|
|
|
|
Net income |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
Basic weighted average common shares outstanding |
|
|
|
|
|
|
|
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
Stock options and restricted stock units |
|
|
|
|
|
|
|
|
Diluted weighted average common shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per basic common share |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
Earnings per diluted common share |
|
$ |
|
|
|
$ |
|
|
11
5. PROPERTY, EQUIPMENT AND LEASEHOLD IMPROVEMENTS, NET
Property, equipment and leasehold improvements, net consisted of the following as of the specified dates:
|
|
As of |
|
|||||
|
|
March 31, |
|
|
December 31, |
|
||
|
|
2021 |
|
|
2020 |
|
||
|
|
(in thousands) |
|
|||||
Computer & related equipment |
|
$ |
|
|
|
$ |
|
|
Furniture & fixtures |
|
|
|
|
|
|
|
|
Leasehold improvements |
|
|
|
|
|
|
|
|
Work-in-process |
|
|
|
|
|
|
|
|
Subtotal |
|
|
|
|
|
|
|
|
Accumulated depreciation and amortization |
|
|
( |
) |
|
|
( |
) |
Property, equipment and leasehold improvements, net |
|
$ |
|
|
|
$ |
|
|
Depreciation and amortization expense of property, equipment and leasehold improvements was $
6. GOODWILL AND INTANGIBLE ASSETS, NET
Goodwill
The following table presents goodwill by reportable segment:
(in thousands) |
|
Index |
|
|
Analytics |
|
|
ESG and Climate |
|
|
All Other - Private Assets |
|
|
Total |
|
|||||
Goodwill at December 31, 2020 |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Foreign exchange translation adjustment |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
Goodwill at March 31, 2021 |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Intangible Assets, Net
The following table presents the amount of amortization expense related to intangible assets by category for the periods indicated:
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
(in thousands) |
|
2021 |
|
|
2020 |
|
||
Amortization expense of acquired intangible assets |
|
$ |
|
|
|
$ |
|
|
Amortization expense of internally developed capitalized software |
|
|
|
|
|
|
|
|
Total amortization of intangible assets expense |
|
$ |
|
|
|
$ |
|
|
12
The gross carrying and accumulated amortization amounts related to the Company’s intangible assets were as follows:
|
|
As of |
|
|||||
|
|
March 31, |
|
|
December 31, |
|
||
|
|
2021 |
|
|
2020 |
|
||
|
|
(in thousands) |
|
|||||
Gross intangible assets: |
|
|
|
|
|
|
|
|
Customer relationships |
|
$ |
|
|
|
$ |
|
|
Trademarks/trade names |
|
|
|
|
|
|
|
|
Technology/software |
|
|
|
|
|
|
|
|
Proprietary data |
|
|
|
|
|
|
|
|
Subtotal |
|
|
|
|
|
|
|
|
Foreign exchange translation adjustment |
|
|
( |
) |
|
|
( |
) |
Total gross intangible assets |
|
$ |
|
|
|
$ |
|
|
Accumulated amortization: |
|
|
|
|
|
|
|
|
Customer relationships |
|
$ |
( |
) |
|
$ |
( |
) |
Trademarks/trade names |
|
|
( |
) |
|
|
( |
) |
Technology/software |
|
|
( |
) |
|
|
( |
) |
Proprietary data |
|
|
( |
) |
|
|
( |
) |
Subtotal |
|
|
( |
) |
|
|
( |
) |
Foreign exchange translation adjustment |
|
|
|
|
|
|
|
|
Total accumulated amortization |
|
$ |
( |
) |
|
$ |
( |
) |
Net intangible assets: |
|
|
|
|
|
|
|
|
Customer relationships |
|
$ |
|
|
|
$ |
|
|
Trademarks/trade names |
|
|
|
|
|
|
|
|
Technology/software |
|
|
|
|
|
|
|
|
Proprietary data |
|
|
|
|
|
|
|
|
Subtotal |
|
|
|
|
|
|
|
|
Foreign exchange translation adjustment |
|
|
( |
) |
|
|
( |
) |
Total net intangible assets |
|
$ |
|
|
|
$ |
|
|
The following table presents the estimated amortization expense for the remainder of the year ending December 31, 2021 and succeeding years:
Years Ending December 31, |
|
Amortization Expense |
|
|
|
|
(in thousands) |
|
|
Remainder of 2021 |
|
$ |
|
|
2022 |
|
|
|
|
2023 |
|
|
|
|
2024 |
|
|
|
|
2025 |
|
|
|
|
Thereafter |
|
|
|
|
Total |
|
$ |
|
|
13
7. COMMITMENTS AND CONTINGENCIES
Senior Unsecured Notes.
|
|
|
|
Principal Amount Outstanding at |
|
|
Carrying Value at |
|
|
Carrying Value at |
|
|
Fair Value at |
|
|
Fair Value at |
|
|||||
|
|
Maturity Date |
|
March 31, 2021 |
|
|
March 31, 2021 |
|
|
December 31, 2020 |
|
|
March 31, 2021 |
|
|
December 31, 2020 |
|
|||||
|
|
(in thousands) |
|
|||||||||||||||||||
Long-term debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total long-term debt |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Interest payments attributable to the Senior Notes are due as presented in the following table:
|
|
First semi-annual interest payment date |
|
Second semi-annual interest payment date |
Senior Notes |
|
|
|
|
4.75% senior unsecured notes due 2026 |
|
|
|
|
5.375% senior unsecured notes due 2027 |
|
|
|
|
4.000% senior unsecured notes due 2029 |
|
|
|
|
3.625% senior unsecured notes due 2030 |
|
|
|
|
3.875% senior unsecured notes due 2031 |
|
|
|
|
The fair market value of the Company’s debt obligations represent Level 2 valuations. The Company utilizes the market approach and obtains security pricing from a vendor who uses broker quotes and third-party pricing services to determine fair values.
On March 26, 2021, the Company issued $
The 2030 Senior Notes are scheduled to mature and be paid in full on
Revolver. Since November 20, 2014, the Company has maintained a revolving credit agreement with a syndicate of banks (as amended, the “Revolving Credit Agreement”). On March 29, 2021, the Company entered into Amendment No. 4 (the “Fourth Amendment”) to the Revolving Credit Agreement. The Fourth Amendment, among other things, (i) increased aggregate commitments available to be borrowed by $
14
point the aggregate commitments will be $
In connection with the closings of the Senior Notes offerings, entry into the Revolving Credit Agreement and the subsequent Amendments, the Company paid certain financing fees which, together with the existing fees related to prior credit facilities, are being amortized over their related lives. At March 31, 2021, $
8. LEASES
The Company recognized a total of $
Future minimum commitments for the Company’s operating leases in place as of March 31, 2021, the interest and other relevant line items in the Unaudited Condensed Consolidated Statement of Financial Condition are as follows:
Maturity of Lease Liabilities |
|
Operating |
|
|
(in thousands) |
|
Leases |
|
|
Remainder of 2021 |
|
$ |
|
|
2022 |
|
|
|
|
2023 |
|
|
|
|
2024 |
|
|
|
|
2025 |
|
|
|
|
Thereafter |
|
|
|
|
Total lease payments |
|
$ |
|
|
Less: Interest |
|
|
( |
) |
Present value of lease liabilities |
|
$ |
|
|
|
|
|
|
|
Other accrued liabilities |
|
$ |
|
|
Long-term operating lease liabilities |
|
$ |
|
|
Lease term and discount rate for the Company’s operating leases in place as of March 31, 2021 are as follows:
|
|
As of |
|
|
|
|
March 31, |
|
|
Lease Term and Discount Rate |
|
2021 |
|
|
Weighted-average remaining lease term (years) |
|
|
|
|
Weighted-average discount rate |
|
|
|
% |
Other information for the Company’s operating leases in place for the three months ended March 31, 2021 are as follows:
|
|
Three Months Ended |
|
|
Other Information |
|
March 31, |
|
|
(in thousands) |
|
2021 |
|
|
Operating cash flows used for operating leases |
|
$ |
|
|
Leased assets obtained in exchange for new operating lease liabilities |
|
$ |
|
|
9. SHAREHOLDERS’ EQUITY (DEFICIT)
Return of capital
On October 29, 2020, the Board of Directors authorized a stock repurchase program for the purchase of up to $
Share repurchases made pursuant to the 2020 Repurchase Program may take place in the open market or in privately negotiated transactions from time to time based on market and other conditions. This authorization may be modified, suspended or terminated by the Board of Directors at any time without prior notice. As of March 31, 2021, there was $
15
The following table provides information with respect to repurchases of the Company’s common stock made on the open market:
Three Months Ended |
|
Average Price Paid Per Share |
|
|
Total Number of Shares Repurchased |
|
|
Dollar Value of Shares Repurchased |
|
|||
|
|
|
|
|
|
(in thousands) |
|
|||||
March 31, 2021 |
|
$ |
|
|
|
|
|
|
|
$ |
|
|
March 31, 2020 |
|
$ |
|
|
|
|
|
|
|
$ |
|
|
The following table presents dividends declared per common share as well as total amounts declared, distributed and deferred for the periods indicated:
|
|
Dividends |
|
|||||||||||||
(in thousands, except per share amounts) |
|
Per Share |
|
|
Declared |
|
|
Distributed |
|
|
(Released)/Deferred |
|
||||
Three Months Ended March 31, 2021 |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
Three Months Ended March 31, 2020 |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
Common Stock.
The following table presents activity related to shares of common stock issued and repurchased during the three months ended March 31, 2021:
|
|
Common Stock |
|
|
Treasury |
|
|
Common Stock |
|
|||
|
|
Issued |
|
|
Stock |
|
|
Outstanding |
|
|||
Balance at December 31, 2020 |
|
|
|
|
|
|
( |
) |
|
|
|
|
Dividend payable/paid |
|
|
|
|
|
|
( |
) |
|
|
|
|
Common stock issued |
|
|
|
|
|
|
— |
|
|
|
|
|
Shares withheld for tax withholding |
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Shares repurchased under stock repurchase programs |
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Shares issued to directors |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Balance at March 31, 2021 |
|
|
|
|
|
|
( |
) |
|
|
|
|
10. INCOME TAXES
The Company’s provision for income taxes was $
The effective tax rate of
The effective tax rate of
The Company is under examination by the IRS and other tax authorities in certain jurisdictions, including foreign jurisdictions, such as the United Kingdom, Switzerland and India, and states in which the Company has significant operations, such as New York. The tax years currently under examination vary by jurisdiction but include years ranging from
16
The Company regularly assesses the likelihood of additional assessments in each of the taxing jurisdictions in which it files income tax returns. The Company has established unrecognized tax benefits that the Company believes are adequate in relation to the potential for additional assessments. Once established, the Company adjusts unrecognized tax benefits only when more information is available or when an event occurs necessitating a change. Based on the current status of income tax audits, the Company believes it is reasonably possible that the total amount of unrecognized benefits may decrease by approximately $
11. SEGMENT INFORMATION
The Company has
Effective January 1, 2021, the Company began presenting
The Index operating segment offers equity and fixed income indexes. The indexes are used in many areas of the investment process, including index-linked product creation (e.g., Exchange Traded Funds (“ETFs”) and futures and options), performance benchmarking, portfolio construction and rebalancing, broker-dealer structured products and asset allocation.
The Analytics operating segment offers risk management, performance attribution and portfolio management content, applications and services that provide clients with an integrated view of risk and return and an analysis of market, credit, liquidity and counterparty risk across all major asset classes, spanning short-, medium- and long-term time horizons. Clients access Analytics content through MSCI’s own proprietary applications and application programming interfaces, third-party applications or directly through their own platforms. Additionally, the Analytics operating segment also provides various managed services to help clients operate more efficiently, including consolidation of client portfolio data from various sources, review and reconciliation of input data and results, and customized reporting.
The ESG and Climate operating segment offers products and services that help institutional investors understand how ESG and climate considerations can impact the long-term risk and return of their portfolio and individual security-level investments. In addition, MSCI ESG Research data and ratings, as well as climate solutions, are used in the construction of equity and fixed income indexes to help institutional investors more effectively benchmark ESG and climate investment performance, issue index-based investment products, as well as manage, measure and report on ESG and climate mandates.
The Real Estate operating segment offers research, reporting, market data and benchmarking offerings that provide real estate performance analysis for funds, investors and managers. Real Estate performance and risk analytics range from enterprise-wide to property-specific analysis. The Real Estate operating segment also provides business intelligence to real estate owners, managers, developers and brokers worldwide.
The Burgiss operating segment represents the Company’s equity method investment in Burgiss, a global provider of investment decision support tools for private capital.
The change in reportable segments has not resulted in any changes to MSCI’s Chief Operating Decision Maker (“CODM”) or the basis for segment profitability from the information disclosed in our 2020 Annual Report on Form 10-K. The CODM continues to measure and evaluate reportable segments based on segment operating revenues as well as Adjusted EBITDA and other measures. The Company excludes the following items from segment Adjusted EBITDA: provision for income taxes, other expense (income), net, depreciation and amortization of property, equipment and leasehold improvements, amortization of intangible assets and, at times, certain other transactions or adjustments, that the CODM does not consider for the purposes of making decisions to allocate resources among segments or to assess segment performance. Although these amounts are excluded from segment Adjusted EBITDA, they are included in reported consolidated net income and are included in the reconciliation that follows.
17
The following table presents operating revenues by reportable segment for the periods indicated:
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
|
|
2021 |
|
|
2020 |
|
||
|
|
(in thousands) |
|
|||||
Operating revenues |
|
|
|
|
|
|
|
|
Index |
|
$ |
|
|
|
$ |
|
|
Analytics |
|
|
|
|
|
|
|
|
ESG and Climate |
|
|
|
|
|
|
|
|
All Other - Private Assets |
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
The following table presents segment profitability and a reconciliation to net income for the periods indicated:
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
|
|
2021 |
|
|
2020 |
|
||
|
|
(in thousands) |
|
|||||
Index Adjusted EBITDA |
|
$ |
|
|
|
$ |
|
|
Analytics Adjusted EBITDA |
|
|
|
|
|
|
|
|
ESG and Climate Adjusted EBITDA |
|
|
|
|
|
|
|
|
All Other - Private Assets Adjusted EBITDA |
|
|
|
|
|
|
|
|
Total operating segment profitability |
|
|
|
|
|
|
|
|
Amortization of intangible assets |
|
|
|
|
|
|
|
|
Depreciation and amortization of property, equipment and leasehold improvements |
|
|
|
|
|
|
|
|
Operating income |
|
|
|
|
|
|
|
|
Other expense (income), net |
|
|
|
|
|
|
|
|
Provision for income taxes |
|
|
|
|
|
|
|
|
Net income |
|
$ |
|
|
|
$ |
|
|
Operating revenues by geography are based on the shipping address of the ultimate customer utilizing the product. The following table presents revenue by geographic area for the periods indicated:
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
|
|
|
2021 |
|
|
|
2020 |
|
|
|
(in thousands) |
|
|||||
Operating revenues |
|
|
|
|
|
|
|
|
Americas: |
|
|
|
|
|
|
|
|
United States |
|
$ |
|
|
|
$ |
|
|
Other |
|
|
|
|
|
|
|
|
Total Americas |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Europe, the Middle East and Africa ("EMEA"): |
|
|
|
|
|
|
|
|
United Kingdom |
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
Total EMEA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asia & Australia: |
|
|
|
|
|
|
|
|
Japan |
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
Total Asia & Australia |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
18
Long-lived assets consist of property, equipment and leasehold improvements, right of use assets and internally developed capitalized software, net of accumulated depreciation and amortization. The following table presents long-lived assets by geographic area on the dates indicated:
|
|
As of |
|
|||||
|
|
March 31, |
|
|
December 31, |
|
||
|
|
2021 |
|
|
2020 |
|
||
|
|
(in thousands) |
|
|||||
Long-lived assets |
|
|
|
|
|
|
|
|
Americas: |
|
|
|
|
|
|
|
|
United States |
|
$ |
|
|
|
$ |
|
|
Other |
|
|
|
|
|
|
|
|
Total Americas |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EMEA: |
|
|
|
|
|
|
|
|
United Kingdom |
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
Total EMEA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asia & Australia: |
|
|
|
|
|
|
|
|
Japan |
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
Total Asia & Australia |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
12. SUBSEQUENT EVENTS
On
19
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of the financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and related notes included elsewhere in this Form 10-Q and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the “Form 10-K”). This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those discussed below. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in “Item 1A.—Risk Factors,” in our Form 10-K.
Except as the context otherwise indicates, the terms “MSCI,” the “Company,” “we,” “our” and “us” refer to MSCI Inc., together with its subsidiaries.
Overview
We are a leading provider of critical decision support tools and services for the global investment community. Leveraging our knowledge of the global investment process and our expertise in research, data and technology, our actionable solutions power better investment decisions by enabling our clients to understand and analyze key drivers of risk and return and confidently and efficiently build more effective portfolios.
Investors all over the world use our tools and services to gain insight and improve transparency throughout their investment processes, including to help define their investment universe, inform and analyze their asset allocation and portfolio construction decisions, measure and manage portfolio performance and risk, conduct performance attribution, implement sustainable and other investment strategies, design and issue ETFs and other indexed financial products, and facilitate reporting to stakeholders.
Our leading research-enhanced products and services include indexes; portfolio construction and risk management analytics; ESG and climate solutions; and real estate benchmarks, return-analytics and market insights. Through our integrated franchise we provide solutions across our products and services to support our clients’ dynamic and complex needs. Our content and capabilities can be accessed by our clients through multiple channels and platforms.
We are focused on product innovation to address the evolving needs of our clients in light of changing investment trends and an increasingly complex industry. In order to most effectively serve our clients, we are committed to driving an integrated solutions-based approach, achieving service excellence, enhancing our differentiated research and content, and delivering flexible, cutting-edge technology and platforms.
Our clients comprise a wide spectrum of the global investment industry and include the following key client types:
|
• |
Asset owners (pension funds, endowments, foundations, central banks, sovereign wealth funds, family offices and insurance companies) |
|
• |
Asset managers (institutional funds and accounts, mutual funds, hedge funds, ETFs, insurance products, private banks and real estate investment trusts) |
|
• |
Financial intermediaries (banks, broker-dealers, exchanges, custodians, trust companies and investment consultants) |
|
• |
Wealth managers (including robo-advisors and self-directed brokerages) |
|
• |
Corporates |
As of March 31, 2021, we served over 4,4001 clients in more than 90 countries. As of March 31, 2021, we had offices in more than 30 cities across more than 20 countries to help serve our diverse client base, with 45.4% of our revenues coming from clients in the Americas, 38.7% in EMEA and 15.9% in Asia and Australia.
Our principal business model is generally to license annual, recurring subscriptions for the majority of our Index, Analytics and ESG and Climate products and services for a fee due in advance of the service period. We also license annual recurring subscriptions for the majority of our Real Estate products for a fee which is primarily paid in arrears after the product is delivered, with the exception of the Market Information product for which the fees are generally paid in advance. A portion of our fees comes from clients who use our indexes as the basis for index-linked investment products. Such fees are primarily based on a client’s assets under management (“AUM”), trading volumes and fee levels.
|
1 |
Represents the aggregate of all related clients under their respective parent entity. |
20
In evaluating our financial performance, we focus on revenue and profit growth, including results accounted for under accounting principles generally accepted in the United States (“GAAP”) as well as non-GAAP measures, for the Company as a whole and by operating segment. In addition, we focus on operating metrics, including Run Rate, subscription sales and Retention Rate, to manage the business. Our business is not highly capital intensive and, as such, we expect to continue to convert a high percentage of our profits into excess cash in the future. Our growth strategy includes: (a) extending leadership in research-enhanced content across asset classes, (b) enhancing distribution and content-enabling technology, (c) expanding solutions that empower client customization, (d) strengthening existing and developing new client relationships and (e) executing strategic relationships and acquisitions with complementary content and technology companies.
In the discussion that follows, we provide certain variances excluding the impact of foreign currency exchange rate fluctuations. Foreign currency exchange rate fluctuations reflect the difference between the current period results as reported compared to the current period results recalculated using the foreign currency exchange rates in effect for the comparable prior period. While operating revenues adjusted for the impact of foreign currency fluctuations includes asset-based fees that have been adjusted for the impact of foreign currency fluctuations, the underlying AUM, which is the primary component of asset-based fees, is not adjusted for foreign currency fluctuations. More than three-fifths of the AUM is invested in securities denominated in currencies other than the U.S. dollar, and accordingly, any such impact is excluded from the disclosed foreign currency-adjusted variances.
The discussion of our results of operations for the three months ended March 31, 2021 and 2020 are presented below. The results of operations for interim periods may not be indicative of future results.
Results of Operations
The following table presents the results of operations for the periods indicated:
|
Three Months Ended |
|
|
|
|
|
|||||
|
March 31, |
|
|
|
|
|
|||||
|
2021 |
|
|
2020 |
|
|
|
|
|
||
|
(in thousands, except per share data) |
|
|||||||||
Operating revenues |
$ |
478,423 |
|
|
$ |
416,780 |
|
|
|
14.8 |
% |
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues |
|
85,780 |
|
|
|
74,609 |
|
|
|
15.0 |
% |
Selling and marketing |
|
56,467 |
|
|
|
55,549 |
|
|
|
1.7 |
% |
Research and development |
|
24,862 |
|
|
|
26,562 |
|
|
|
(6.4 |
%) |
General and administrative |
|
34,728 |
|
|
|
30,833 |
|
|
|
12.6 |
% |
Amortization of intangible assets |
|
15,068 |
|
|
|
13,776 |
|
|
|
9.4 |
% |
Depreciation and amortization of property, equipment and leasehold improvements |
|
7,143 |
|
|
|
7,567 |
|
|
|
(5.6 |
%) |
Total operating expenses |
|
224,048 |
|
|
|
208,896 |
|
|
|
7.3 |
% |
Operating income |
|
254,375 |
|
|
|
207,884 |
|
|
|
22.4 |
% |
Other expense (income), net |
|
38,347 |
|
|
|
45,035 |
|
|
|
(14.9 |
%) |
Income before provision for income taxes |
|
216,028 |
|
|
|
162,849 |
|
|
|
32.7 |
% |
Provision for income taxes |
|
19,209 |
|
|
|
14,724 |
|
|
|
30.5 |
% |
Net income |
$ |
196,819 |
|
|
$ |
148,125 |
|
|
|
32.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per basic common share |
$ |
2.38 |
|
|
$ |
1.75 |
|
|
|
36.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per diluted common share |
$ |
2.36 |
|
|
$ |
1.73 |
|
|
|
36.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
Operating margin |
|
53.2 |
% |
|
|
49.9 |
% |
|
|
|
|
Operating Revenues
Our revenues are grouped by the following types: recurring subscriptions, asset-based fees and non-recurring. We also group revenues by major product or reportable segment as follows: Index, Analytics, ESG and Climate and All Other – Private Assets, which includes the Real Estate product line.
21
The following table presents operating revenues by type for the periods indicated:
|
Three Months Ended |
|
|
|
|
|
|
|||||
|
March 31, |
|
|
|
|
|
|
|||||
|
2021 |
|
|
2020 |
|
|
% Change |
|
|
|||
|
(in thousands) |
|||||||||||
Recurring subscriptions |
$ |
337,732 |
|
|
$ |
304,425 |
|
|
|
10.9 |
% |
|
Asset-based fees |
|
126,706 |
|
|
|
100,196 |
|
|
|
26.5 |
% |
|
Non-recurring |
|
13,985 |
|
|
|
12,159 |
|
|
|
15.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating revenues |
$ |
478,423 |
|
|
$ |
416,780 |
|
|
|
14.8 |
% |
|
Total operating revenues for the three months ended March 31, 2021 increased 14.8% to $478.4 million compared to $416.8 million for the three months ended March 31, 2020. Adjusting for the impact of foreign currency exchange rate fluctuations, the increase would have been 14.0% for the three months ended March 31, 2021 compared to the three months ended March 31, 2020.
Operating revenues from recurring subscriptions for the three months ended March 31, 2021 increased 10.9% to $337.7 million compared to $304.4 million for the three months ended March 31, 2020, primarily driven by growth in Index products, which increased $15.3 million, or 10.9%, strong growth in ESG and Climate products, which increased $9.2 million, or 37.1%, and growth in Analytics products, which increased $7.6 million, or 6.1%. Adjusting for the impact of foreign currency exchange rate fluctuations, the increase would have been 9.9% for the three months ended March 31, 2021 compared to the three months ended March 31, 2020.
Operating revenues from asset-based fees for the three months ended March 31, 2021 increased 26.5% to $126.7 million compared to $100.2 million for the three months ended March 31, 2020. The increase in asset-based fees was driven by growth in revenues from all of our indexed investment product categories, including an increase in revenues from ETFs linked to MSCI equity indexes that was primarily driven by a 33.3% increase in average AUM in ETFs, partially offset by a change in fee levels of certain products. The increase in revenues from asset-based fees was also driven by higher revenues from non-ETF indexed funds linked to MSCI indexes resulting from new funds and increased demand in ESG products and climate products. Revenues from exchange traded futures and options contracts linked to MSCI indexes also increased, primarily driven by price increases, partially offset by lower volume. The impact of foreign currency exchange rate fluctuations on revenues from asset-based fees was negligible.
The following table presents the value of AUM in ETFs linked to MSCI equity indexes and the sequential change of such assets as of the end of each of the periods indicated:
|
|
Period Ended |
|
|||||||||||||||||
|
|
2020 |
|
|
2021 |
|
||||||||||||||
(in billions) |
|
March 31, |
|
|
June 30, |
|
|
September 30, |
|
|
December 31, |
|
|
March 31, |
|
|||||
AUM in ETFs linked to MSCI equity indexes(1), (2) |
|
$ |
709.5 |
|
|
$ |
825.4 |
|
|
$ |
908.9 |
|
|
$ |
1,103.6 |
|
|
$ |
1,209.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sequential Change in Value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market Appreciation/(Depreciation) |
|
$ |
(216.5 |
) |
|
$ |
117.4 |
|
|
$ |
57.0 |
|
|
$ |
135.7 |
|
|
$ |
43.2 |
|
Cash Inflows |
|
|
(8.4 |
) |
|
|
(1.5 |
) |
|
|
26.5 |
|
|
|
59.0 |
|
|
|
62.8 |
|
Total Change |
|
$ |
(224.9 |
) |
|
$ |
115.9 |
|
|
$ |
83.5 |
|
|
$ |
194.7 |
|
|
$ |
106.0 |
|
The following table presents the average value of AUM in ETFs linked to MSCI equity indexes for the periods indicated:
|
|
2020 |
|
|
2021 |
|
||||||||||||||
(in billions) |
|
March |
|
|
June |
|
|
September |
|
|
December |
|
|
March |
|
|||||
AUM in ETFs linked to MSCI equity indexes(1), (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarterly average |
|
$ |
877.1 |
|
|
$ |
776.9 |
|
|
$ |
893.4 |
|
|
$ |
999.2 |
|
|
$ |
1,169.2 |
|
Year-to-date average |
|
$ |
877.1 |
|
|
$ |
827.0 |
|
|
$ |
849.1 |
|
|
$ |
886.7 |
|
|
$ |
1,169.2 |
|
(1) |
The historical values of the AUM in ETFs linked to our equity indexes as of the last day of the month and the monthly average balance can be found under the link “AUM in ETFs Linked to MSCI Equity Indexes” on our Investor Relations homepage at http://ir.msci.com. This information is updated mid-month each month. Information contained on our website is not incorporated by reference into this Quarterly Report on Form 10-Q or any other report filed with the SEC. The AUM in ETFs also includes AUM in Exchange Traded Notes, the value of which is less than 1.0% of the AUM amounts presented. |
(2) |
The value of AUM in ETFs linked to MSCI equity indexes is calculated by multiplying the equity ETF net asset value by the number of shares outstanding. |
The average value of AUM in ETFs linked to MSCI equity indexes for the three months ended March 31, 2021 was $1,169.2 billion, up $292.1 billion, or 33.3%, from $877.1 billion for the three months ended March 31, 2020.
22
Non-recurring revenues for the three months ended March 31, 2021 increased 15.0% to $14.0 million compared to $12.2 million for the three months ended March 31, 2020, primarily driven by growth in Index products, which increased $1.4 million, or 15.7%.
The following table presents operating revenues by reportable segment and revenue type for the periods indicated:
|
Three Months Ended |
|
|
|
|
|
|
|||||
|
March 31, |
|
|
|
|
|
|
|||||
|
2021 |
|
|
2020 |
|
|
% Change |
|
|
|||
|
(in thousands) |
|||||||||||
Operating revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
Index |
|
|
|
|
|
|
|
|
|
|
|
|
Recurring subscriptions |
$ |
155,117 |
|
|
$ |
139,840 |
|
|
|
10.9 |
% |
|
Asset-based fees |
|
126,706 |
|
|
|
100,196 |
|
|
|
26.5 |
% |
|
Non-recurring |
|
10,668 |
|
|
|
9,220 |
|
|
|
15.7 |
% |
|
Index total |
|
292,491 |
|
|
|
249,256 |
|
|
|
17.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Analytics |
|
|
|
|
|
|
|
|
|
|
|
|
Recurring subscriptions |
|
131,672 |
|
|
|
124,065 |
|
|
|
6.1 |
% |
|
Non-recurring |
|
2,345 |
|
|
|
1,443 |
|
|
|
62.5 |
% |
|
Analytics total |
|
134,017 |
|
|
|
125,508 |
|
|
|
6.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ESG and Climate |
|
|
|
|
|
|
|
|
|
|
|
|
Recurring subscriptions |
|
34,140 |
|
|
|
24,901 |
|
|
|
37.1 |
% |
|
Non-recurring |
|
610 |
|
|
|
332 |
|
|
|
83.7 |
% |
|
ESG and Climate total |
|
34,750 |
|
|
|
25,233 |
|
|
|
37.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other - Private Assets |
|
|
|
|
|
|
|
|
|
|
|
|
Recurring subscriptions |
|
16,803 |
|
|
|
15,619 |
|
|
|
7.6 |
% |
|
Non-recurring |
|
362 |
|
|
|
1,164 |
|
|
|
(68.9 |
%) |
|
All Other - Private Assets total |
|
17,165 |
|
|
|
16,783 |
|
|
|
2.3 |
% |
|
Total operating revenues |
$ |
478,423 |
|
|
$ |
416,780 |
|
|
|
14.8 |
% |
|
Refer to the section titled "Segment Results" that follows for further discussion of segment revenues.
Operating Expenses
We group our operating expenses into the following activity categories:
|
• |
Cost of revenues; |
|
• |
Selling and marketing; |
|
• |
Research and development (“R&D”); |
|
• |
General and administrative (“G&A”); |
|
• |
Amortization of intangible assets; and |
|
• |
Depreciation and amortization of property, equipment and leasehold improvements. |
23
Costs are assigned to these activity categories based on the nature of the expense or, when not directly attributable, an estimated allocation based on the type of effort involved.
The following table presents operating expenses by activity category for the periods indicated:
|
Three Months Ended |
|
|
|
|
|
|||||
|
March 31, |
|
|
|
|
|
|||||
|
2021 |
|
|
2020 |
|
|
% Change |
|
|||
|
(in thousands) |
|
|||||||||
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues |
$ |
85,780 |
|
|
$ |
74,609 |
|
|
|
15.0 |
% |
Selling and marketing |
|
56,467 |
|
|
|
55,549 |
|
|
|
1.7 |
% |
Research and development |
|
24,862 |
|
|
|
26,562 |
|
|
|
(6.4 |
%) |
General and administrative |
|
34,728 |
|
|
|
30,833 |
|
|
|
12.6 |
% |
Amortization of intangible assets |
|
15,068 |
|
|
|
13,776 |
|
|
|
9.4 |
% |
Depreciation and amortization of property, equipment and leasehold improvements |
|
7,143 |
|
|
|
7,567 |
|
|
|
(5.6 |
%) |
Total operating expenses |
$ |
224,048 |
|
|
$ |
208,896 |
|
|
|
7.3 |
% |
Total operating expenses for the three months ended March 31, 2021 increased 7.3% to $224.0 million compared to $208.9 million for the three months ended March 31, 2020. Adjusting for the impact of foreign currency exchange rate fluctuations, the increase would have been 5.4% for the three months ended March 31, 2021 compared to the three months ended March 31, 2020.
Cost of Revenues
Cost of revenues expenses consist of costs related to the production and servicing of our products and services and primarily includes related information technology costs, including data center, cloud service, platform and infrastructure costs; costs to acquire, produce and maintain market data information; costs of research to support and maintain existing products; costs of product management teams; costs of client service and consultant teams to support customer needs; as well as other support costs directly attributable to the cost of revenues including certain human resources, finance and legal costs.
Cost of revenues for the three months ended March 31, 2021 increased 15.0% to $85.8 million compared to $74.6 million for the three months ended March 31, 2020, reflecting increases across all four reportable segments. The change was driven by increases in compensation and benefits costs, primarily relating to higher incentive compensation, wages and salaries and benefits costs, as well as higher non-compensation costs, reflecting higher information technology costs, professional fees and market data costs, partially offset by lower travel and entertainment costs.
Selling and Marketing
Selling and marketing expenses consist of costs associated with acquiring new clients or selling new products or product renewals to existing clients and primarily includes the costs of our sales and marketing teams, as well as costs incurred in other groups associated with acquiring new business, including product management, research, technology and sales operations.
Selling and marketing expenses for the three months ended March 31, 2021 increased 1.7% to $56.5 million compared to $55.5 million for the three months ended March 31, 2020, driven by higher costs in the ESG and Climate reportable segment, partially offset by lower costs in the Analytics reportable segment. The change was driven by increases in compensation and benefits costs, including severance costs, wages and salaries and incentive compensation, partially offset by decreases in non-compensation costs, primarily relating to lower travel and entertainment costs, marketing costs and recruiting costs.
Research and Development
R&D expenses consist of the costs to develop new or enhance existing products and the costs to develop new or improved technology and service platforms for the delivery of our products and services and primarily include the costs of development, research, product management, project management and the technology support associated with these efforts.
R&D expenses for the three months ended March 31, 2021 decreased 6.4% to $24.9 million compared to $26.6 million for the three months ended March 31, 2020, reflecting higher allocation of resources to projects eligible for capitalization across all of the segments, leading to a decline in compensation and benefits costs, primarily wages and salaries, expensed as R&D.
24
General and Administrative
G&A expenses consist of costs primarily related to finance operations, human resources, office of the CEO, legal, corporate technology, corporate development and certain other administrative costs that are not directly attributed, but are instead allocated, to a product or service.
G&A expenses for the three months ended March 31, 2021 increased 12.6% to $34.7 million compared to $30.8 million for the three months ended March 31, 2020, reflecting increases across all four reportable segments. The change was driven by increases in compensation and benefits costs, primarily relating to higher incentive compensation.
The following table presents operating expenses using compensation and non-compensation categories, rather than using activity categories, for the periods indicated:
|
Three Months Ended |
|
|
|
|
|
|||||
|
March 31, |
|
|
|
|
|
|||||
|
2021 |
|
|
2020 |
|
|
% Change |
|
|||
|
(in thousands) |
|
|||||||||
Compensation and benefits |
$ |
151,517 |
|
|
$ |
137,262 |
|
|
|
10.4 |
% |
Non-compensation expenses |
|
50,320 |
|
|
|
50,291 |
|
|
|
0.1 |
% |
Amortization of intangible assets |
|
15,068 |
|
|
|
13,776 |
|
|
|
9.4 |
% |
Depreciation and amortization of property, equipment and leasehold improvements |
|
7,143 |
|
|
|
7,567 |
|
|
|
(5.6 |
%) |
Total operating expenses |
$ |
224,048 |
|
|
$ |
208,896 |
|
|
|
7.3 |
% |
Compensation and Benefits
Compensation and benefits costs are our most significant expense and typically represent approximately 65% of operating expenses or more than 70% of Adjusted EBITDA expenses. We had 3,728 and 3,459 employees as of March 31, 2021 and 2020, respectively, reflecting a 7.8% growth in the number of employees. Continued growth of our emerging market centers around the world is an important factor in our ability to manage and control the growth of our compensation and benefit expenses. As of March 31, 2021, 64.9% of our employees were located in emerging market centers compared to 63.3% as of March 31, 2020.
Compensation and benefits costs for the three months ended March 31, 2021 increased 10.4% to $151.5 million compared to $137.3 million for the three months ended March 31, 2020, driven by higher incentive compensation, wages and salaries and benefits costs, partially offset by lower severance costs.
A significant portion of the incentive compensation component of operating expenses is based on the achievement of a number of financial and operating metrics. In a scenario where operating revenue growth and profitability moderate, incentive compensation would be expected to decrease accordingly.
Non-Compensation Expenses
Non-compensation expenses of $50.3 million for the three months ended March 31, 2021 remained consistent compared to the three months ended March 31, 2020.
Fixed costs constitute a significant portion of the non-compensation component of operating expenses. The discretionary non-compensation component of operating expenses could, however, be reduced in the near-term in a scenario where operating revenue growth moderates.
Amortization of Intangible Assets
Amortization of intangible assets expense relates to definite-lived intangible assets arising from past acquisitions and internal capitalized software projects recognized over their estimated useful lives. Amortization of intangible assets expense for the three months ended March 31, 2021 increased 9.4% to $15.1 million compared to $13.8 million for the three months ended March 31, 2020, primarily driven by higher amortization of internally developed capitalized software.
25
Depreciation and Amortization of Property, Equipment and Leasehold Improvements
Depreciation and amortization of property, equipment and leasehold improvements consists of expenses related to depreciating or amortizing the cost of furniture and fixtures, computer and related equipment and leasehold improvements over the estimated useful life of the assets. Depreciation and amortization of property, equipment and leasehold improvements for the three months ended March 31, 2021 decreased 5.6% to $7.1 million compared to $7.6 million for the three months ended March 31, 2020. The decrease was primarily the result of lower depreciation on computer and related equipment, software and leasehold improvements, partially offset by higher depreciation on furniture.
Other Expense (Income), Net
Other expense (income), net for the three months ended March 31, 2021 decreased 14.9% to $38.3 million compared to $45.0 million for the three months ended March 31, 2020. The decrease in net expenses was primarily driven by the absence of the $10.0 million loss on debt extinguishment associated with the redemption of all of the $300.0 million aggregate principal amount of 5.250% senior unsecured notes due 2024 that remained outstanding (the “2024 Senior Notes Redemption”) during the three months ended March 31, 2020.
Income Taxes
The Company’s provision for income taxes for the three months ended March 31, 2021 and 2020 was $19.2 million and $14.7 million, respectively. These amounts reflect effective tax rates of 8.9% and 9.0% for the three months ended March 31, 2021 and 2020, respectively.
The effective tax rate of 8.9% for the three months ended March 31, 2021 reflects the Company’s estimate of the effective tax rate for the period which was impacted by certain favorable discrete items totaling $22.3 million. For the three months ended March 31, 2021, these discrete items primarily related to $20.4 million of excess tax benefits recognized on share-based compensation vested during the period.
The effective tax rate of 9.0% for the three months ended March 31, 2020 reflects the Company’s estimate of the effective tax rate for the period which was impacted by certain favorable discrete items totaling $22.4 million. For the three months ended March 31, 2020, these discrete items primarily related to $18.9 million of excess tax benefits recognized on share-based compensation vested during the period and $2.6 million related to the tax impact of loss on debt extinguishment recognized during the period. The discrete items also included a $0.8 million benefit related to the revaluation of the cost of deemed repatriation of foreign earnings.
Net Income
As a result of the factors described above, net income for the three months ended March 31, 2021 increased 32.9% to $196.8 million compared to $148.1 million for the three months ended March 31, 2020.
Weighted Average Shares
The weighted average shares outstanding used to calculate basic and diluted earnings per share for the three months ended March 31, 2021 compared to the three months ended March 31, 2020 decreased by 2.6% and 2.4%, respectively. The decreases primarily reflect the impact of share repurchases made pursuant to the stock repurchase program.
Adjusted EBITDA
“Adjusted EBITDA,” a non-GAAP measure used by management to assess operating performance, is defined as net income before (1) provision for income taxes, (2) other expense (income), net, (3) depreciation and amortization of property, equipment and leasehold improvements, (4) amortization of intangible assets and, at times, (5) certain other transactions or adjustments.
“Adjusted EBITDA expenses,” a non-GAAP measure used by management to assess operating performance, is defined as operating expenses less depreciation and amortization of property, equipment and leasehold improvements and amortization of intangible assets and, at times, certain other transactions or adjustments.
Adjusted EBITDA and Adjusted EBITDA expenses are believed to be meaningful measures of the operating performance of the Company because they adjust for significant one-time, unusual or non-recurring items as well as eliminate the accounting effects of certain capital spending and acquisitions that do not directly affect what management considers to be the Company’s ongoing operating performance in the period. All companies do not calculate adjusted EBITDA and adjusted EBITDA expenses in the same way. These measures can differ significantly from company to company depending on, among other things, long-term strategic decisions regarding capital structure, the tax jurisdictions in which companies operate and capital investments. Accordingly, the Company’s computation of the Adjusted EBITDA and Adjusted EBITDA expenses measures may not be comparable to similarly titled measures computed by other companies.
26
The following table presents the calculation of Adjusted EBITDA for the periods indicated:
|
Three Months Ended |
|
|
|
|
|
|||||
|
March 31, |
|
|
|
|
|
|||||
|
2021 |
|
|
2020 |
|
|
% Change |
|
|||
|
(in thousands) |
|
|||||||||
Operating revenues |
$ |
478,423 |
|
|
$ |
416,780 |
|
|
|
14.8 |
% |
Adjusted EBITDA expenses |
|
201,837 |
|
|
|
187,553 |
|
|
|
7.6 |
% |
Adjusted EBITDA |
$ |
276,586 |
|
|
$ |
229,227 |
|
|
|
20.7 |
% |
Adjusted EBITDA margin % |
|
57.8 |
% |
|
|
55.0 |
% |
|
|
|
|
Operating margin % |
|
53.2 |
% |
|
|
49.9 |
% |
|
|
|
|
Adjusted EBITDA for the three months ended March 31, 2021 increased 20.7% to $276.6 million compared to $229.2 million for the three months ended March 31, 2020. Adjusted EBITDA margin for the three months ended March 31, 2021 increased to 57.8% compared to 55.0% for the three months ended March 31, 2020. The increase in Adjusted EBITDA margin reflects a higher rate of growth in operating revenues as compared to the rate of growth of Adjusted EBITDA expenses.
Reconciliation of Adjusted EBITDA to Net Income and Adjusted EBITDA Expenses to Operating Expenses
The following table presents the reconciliation of Adjusted EBITDA to net income for the periods indicated:
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
|
|
2021 |
|
|
2020 |
|
||
|
|
(in thousands) |
|
|||||
Index Adjusted EBITDA |
|
$ |
219,879 |
|
|
$ |
183,587 |
|
Analytics Adjusted EBITDA |
|
|
45,731 |
|
|
|
36,317 |
|
ESG and Climate Adjusted EBITDA |
|
|
5,045 |
|
|
|
3,626 |
|
All Other - Private Assets Adjusted EBITDA |
|
|
5,931 |
|
|
|
5,697 |
|
Consolidated Adjusted EBITDA |
|
|
276,586 |
|
|
|
229,227 |
|
Amortization of intangible assets |
|
|
15,068 |
|
|
|
13,776 |
|
Depreciation and amortization of property, equipment and leasehold improvements |
|
|
7,143 |
|
|
|
7,567 |
|
Operating income |
|
|
254,375 |
|
|
|
207,884 |
|
Other expense (income), net |
|
|
38,347 |
|
|
|
45,035 |
|
Provision for income taxes |
|
|
19,209 |
|
|
|
14,724 |
|
Net income |
|
$ |
196,819 |
|
|
$ |
148,125 |
|
The following table presents the reconciliation of Adjusted EBITDA expenses to operating expenses for the periods indicated:
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
|
|
2021 |
|
|
2020 |
|
||
|
|
(in thousands) |
|
|||||
Index Adjusted EBITDA expenses |
|
$ |
72,612 |
|
|
$ |
65,669 |
|
Analytics Adjusted EBITDA expenses |
|
|
88,286 |
|
|
|
89,191 |
|
ESG and Climate Adjusted EBITDA expenses |
|
|
29,705 |
|
|
|
21,607 |
|
All Other - Private Assets Adjusted EBITDA expenses |
|
|
11,234 |
|
|
|
11,086 |
|
Consolidated Adjusted EBITDA expenses |
|
|
201,837 |
|
|
|
187,553 |
|
Amortization of intangible assets |
|
|
15,068 |
|
|
|
13,776 |
|
Depreciation and amortization of property, equipment and leasehold improvements |
|
|
7,143 |
|
|
|
7,567 |
|
Total operating expenses |
|
$ |
224,048 |
|
|
$ |
208,896 |
|
The discussion of the segment results is presented below.
27
Segment Results
Index Segment
The following table presents the results for the Index segment for the periods indicated:
|
Three Months Ended |
|
|
|
|
|
|||||
|
March 31, |
|
|
|
|
|
|||||
|
2021 |
|
|
2020 |
|
|
% Change |
|
|||
|
(in thousands) |
|
|||||||||
Operating revenues: |
|
|
|
|
|
|
|
|
|
|
|
Recurring subscriptions |
$ |
155,117 |
|
|
$ |
139,840 |
|
|
|
10.9 |
% |
Asset-based fees |
|
126,706 |
|
|
|
100,196 |
|
|
|
26.5 |
% |
Non-recurring |
|
10,668 |
|
|
|
9,220 |
|
|
|
15.7 |
% |
Operating revenues total |
|
292,491 |
|
|
|
249,256 |
|
|
|
17.3 |
% |
Adjusted EBITDA expenses |
|
72,612 |
|
|
|
65,669 |
|
|
|
10.6 |
% |
Adjusted EBITDA |
$ |
219,879 |
|
|
$ |
183,587 |
|
|
|
19.8 |
% |
Adjusted EBITDA margin % |
|
75.2 |
% |
|
|
73.7 |
% |
|
|
|
|
Revenues related to Index products for the three months ended March 31, 2021 increased 17.3% to $292.5 million compared to $249.3 million for the three months ended March 31, 2020.
Recurring subscriptions for the three months ended March 31, 2021 increased 10.9% to $155.1 million compared to $139.8 million for the three months ended March 31, 2020. The increase was primarily driven by strong growth in market cap-weighted index products. The impact of foreign currency exchange rate fluctuations on revenues from recurring subscriptions was negligible.
Revenues from asset-based fees for the three months ended March 31, 2021 increased 26.5% to $126.7 million compared to $100.2 million for the three months ended March 31, 2020. The increase in asset-based fees was driven by growth in revenues from all of our indexed investment product categories, including an increase in revenues from ETFs linked to MSCI equity indexes that was primarily driven by a 33.3% increase in average AUM in ETFs, partially offset by a change in fee levels of certain products. The increase in revenues from asset-based fees was also driven by higher revenues from non-ETF indexed funds linked to MSCI indexes resulting from new funds and increased demand in ESG products and climate products. Revenues from exchange traded futures and options contracts linked to MSCI indexes also increased, primarily driven by price increases, partially offset by lower volume. The impact of foreign currency exchange rate fluctuations on revenues from asset-based fees was negligible.
Index segment Adjusted EBITDA expenses for the three months ended March 31, 2021 increased 10.6% to $72.6 million compared to $65.7 million for the three months ended March 31, 2020, reflecting higher expenses across the cost of revenues and G&A expense activity categories. Adjusting for the impact of foreign currency exchange rate fluctuations, the increase would have been 8.4% for the three months ended March 31, 2021 compared to the three months ended March 31, 2020.
Analytics Segment
The following table presents the results for the Analytics segment for the periods indicated:
|
Three Months Ended |
|
|
|
|
|
|||||
|
March 31, |
|
|
|
|
|
|||||
|
2021 |
|
|
2020 |
|
|
% Change |
|
|||
|
(in thousands) |
|
|||||||||
Operating revenues: |
|
|
|
|
|
|
|
|
|
|
|
Recurring subscriptions |
$ |
131,672 |
|
|
$ |
124,065 |
|
|
|
6.1 |
% |
Non-recurring |
|
2,345 |
|
|
|
1,443 |
|
|
|
62.5 |
% |
Operating revenues total |
|
134,017 |
|
|
|
125,508 |
|
|
|
6.8 |
% |
Adjusted EBITDA expenses |
|
88,286 |
|
|
|
89,191 |
|
|
|
(1.0 |
%) |
Adjusted EBITDA |
$ |
45,731 |
|
|
$ |
36,317 |
|
|
|
25.9 |
% |
Adjusted EBITDA margin % |
|
34.1 |
% |
|
|
28.9 |
% |
|
|
|
|
Analytics segment revenues for the three months ended March 31, 2021 increased 6.8% to $134.0 million compared to $125.5 million for the three months ended March 31, 2020, primarily driven by growth in Multi-Asset Class and Equity Analytics products. Adjusting for the impact of foreign currency exchange rate fluctuations, the increase would have been 6.6% for the three months ended March 31, 2021 compared to the three months ended March 31, 2020.
28
Analytics segment Adjusted EBITDA expenses for the three months ended March 31, 2021 decreased 1.0% to $88.3 million compared to $89.2 million for the three months ended March 31, 2020, primarily driven by lower expenses across the R&D and selling and marketing expense activity categories, partially offset by higher expenses across the G&A and cost of revenues expense activity categories. Adjusting for the impact of foreign currency exchange rate fluctuations, the decrease would have been 2.4% for the three months ended March 31, 2021 compared to the three months ended March 31, 2020.
ESG and Climate Segment
The following table presents the results for the ESG and Climate segment for the periods indicated:
|
Three Months Ended |
|
|
|
|
|
|||||
|
March 31, |
|
|
|
|
|
|||||
|
2021 |
|
|
2020 |
|
|
% Change |
|
|||
|
(in thousands) |
|
|||||||||
Operating revenues: |
|
|
|
|
|
|
|
|
|
|
|
Recurring subscriptions |
$ |
34,140 |
|
|
$ |
24,901 |
|
|
|
37.1 |
% |
Non-recurring |
|
610 |
|
|
|
332 |
|
|
|
83.7 |
% |
Operating revenues total |
|
34,750 |
|
|
|
25,233 |
|
|
|
37.7 |
% |
Adjusted EBITDA expenses |
|
29,705 |
|
|
|
21,607 |
|
|
|
37.5 |
% |
Adjusted EBITDA |
$ |
5,045 |
|
|
$ |
3,626 |
|
|
|
39.1 |
% |
Adjusted EBITDA margin % |
|
14.5 |
% |
|
|
14.4 |
% |
|
|
|
|
ESG and Climate segment revenues for the three months ended March 31, 2021 increased 37.7% to $34.8 million compared to $25.2 million for the three months ended March 31, 2020. The increase in ESG and Climate revenues was primarily driven by strong growth from Ratings and Climate products. Adjusting for the impact of foreign currency exchange rate fluctuations, ESG and Climate operating revenues would have increased 31.8%, for the three months ended March 31, 2021 compared to the three months ended March 31, 2020.
ESG and Climate segment Adjusted EBITDA expenses for the three months ended March 31, 2021 increased 37.5% to $29.7 million compared to $21.6 million for the three months ended March 31, 2020, reflecting higher expenses across all expense activity categories. Adjusting for the impact of foreign currency exchange rate fluctuations, the increase would have been 34.0% for the three months ended March 31, 2021 compared to the three months ended March 31, 2020.
All Other – Private Assets Segment
The following table presents the results for the All Other – Private Assets segment for the periods indicated:
|
Three Months Ended |
|
|
|
|
|
|||||
|
March 31, |
|
|
|
|
|
|||||
|
2021 |
|
|
2020 |
|
|
% Change |
|
|||
|
(in thousands) |
|
|||||||||
Operating revenues: |
|
|
|
|
|
|
|
|
|
|
|
Recurring subscriptions |
$ |
16,803 |
|
|
$ |
15,619 |
|
|
|
7.6 |
% |
Non-recurring |
|
362 |
|
|
|
1,164 |
|
|
|
(68.9 |
%) |
Operating revenues total |
|
17,165 |
|
|
|
16,783 |
|
|
|
2.3 |
% |
Adjusted EBITDA expenses |
|
11,234 |
|
|
|
11,086 |
|
|
|
1.3 |
% |
Adjusted EBITDA |
$ |
5,931 |
|
|
$ |
5,697 |
|
|
|
4.1 |
% |
Adjusted EBITDA margin % |
|
34.6 |
% |
|
|
33.9 |
% |
|
|
|
|
All Other – Private Assets segment revenues for the three months ended March 31, 2021 increased 2.3% to $17.2 million compared to $16.8 million for the three months ended March 31, 2020. The increase in All Other – Private Assets revenues was primarily driven by favorable foreign currency exchange rate fluctuations, partially offset by the absence of a previously disclosed one-time data license fee recognized during the three months ended March 31, 2020. Adjusting for the impact of foreign currency exchange rate fluctuations, All Other – Private Assets operating revenues would have decreased 5.6% for the three months ended March 31, 2021 compared to the three months ended March 31, 2020.
All Other – Private Assets segment Adjusted EBITDA expenses for the three months ended March 31, 2021 increased 1.3% to $11.2 million compared to $11.1 million for the three months ended March 31, 2020, primarily driven by higher expenses across the cost of revenues and G&A expense activity categories, partially offset by lower expenses across the R&D and selling and marketing expense activity categories. Adjusting for the impact of foreign currency exchange rate fluctuations, All Other – Private Assets segment Adjusted EBITDA expenses would have decreased 2.2% for the three months ended March 31, 2021 compared to the three months ended March 31, 2020.
29
Run Rate
“Run Rate” estimates at a particular point in time the annualized value of the recurring revenues under our client license agreements (“Client Contracts”) for the next 12 months, assuming all Client Contracts that come up for renewal are renewed and assuming then-current currency exchange rates, subject to the adjustments and exclusions described below. For any Client Contract where fees are linked to an investment product’s assets or trading volume/fees, the Run Rate calculation reflects, for ETFs, the market value on the last trading day of the period, for futures and options, the most recent quarterly volumes and/or reported exchange fees, and for other non-ETF products, the most recent client-reported assets. Run Rate does not include fees associated with “one-time” and other non-recurring transactions. In addition, we add to Run Rate the annualized fee value of recurring new sales, whether to existing or new clients, when we execute Client Contracts, even though the license start date, and associated revenue recognition, may not be effective until a later date. We remove from Run Rate the annualized fee value associated with products or services under any Client Contract with respect to which we have received a notice of termination or non-renewal during the period and have determined that such notice evidences the client’s final decision to terminate or not renew the applicable products or services, even though such notice is not effective until a later date.
Changes in our recurring revenues typically lag changes in Run Rate. The actual amount of recurring revenues we will realize over the following 12 months will differ from Run Rate for numerous reasons, including:
|
• |
fluctuations in revenues associated with new recurring sales; |
|
• |
modifications, cancellations and non-renewals of existing Client Contracts, subject to specified notice requirements; |
|
• |
differences between the recurring license start date and the date the Client Contract is executed due to, for example, contracts with onboarding periods or fee waiver periods; |
|
• |
fluctuations in asset-based fees, which may result from changes in certain investment products’ total expense ratios, market movements, including foreign currency exchange rates, or from investment inflows into and outflows from investment products linked to our indexes; |
|
• |
fluctuations in fees based on trading volumes of futures and options contracts linked to our indexes; |
|
• |
fluctuations in the number of hedge funds for which we provide investment information and risk analysis to hedge fund investors; |
|
• |
price changes or discounts; |
|
• |
revenue recognition differences under U.S. GAAP, including those related to the timing of implementation and report deliveries for certain of our products and services; |
|
• |
fluctuations in foreign currency exchange rates; and |
|
• |
the impact of acquisitions and divestitures. |
30
The following table presents the Run Rates as of the dates indicated and the growth percentages over the periods indicated:
|
As of |
|
|
|
|
|
|||||
|
March 31, |
|
|
March 31, |
|
|
% |
|
|||
|
|
2021 |
|
|
|
2020 |
|
|
Change |
|
|
|
(in thousands) |
|
|
|
|||||||
Index: |
|
|
|
|
|
|
|
|
|
|
|
Recurring subscriptions |
$ |
634,565 |
|
|
$ |
574,132 |
|
|
|
10.5 |
% |
Asset-based fees |
|
503,207 |
|
|
|
348,218 |
|
|
|
44.5 |
% |
Index total |
|
1,137,772 |
|
|
|
922,350 |
|
|
|
23.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
Analytics |
|
556,997 |
|
|
|
528,378 |
|
|
|
5.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
ESG and Climate |
|
147,334 |
|
|
|
103,781 |
|
|
|
42.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
All Other - Private Assets |
|
56,900 |
|
|
|
49,671 |
|
|
|
14.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
Total Run Rate |
$ |
1,899,003 |
|
|
$ |
1,604,180 |
|
|
|
18.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
Recurring subscriptions total |
$ |
1,395,796 |
|
|
$ |
1,255,962 |
|
|
|
11.1 |
% |
Asset-based fees |
|
503,207 |
|
|
|
348,218 |
|
|
|
44.5 |
% |
Total Run Rate |
$ |
1,899,003 |
|
|
$ |
1,604,180 |
|
|
|
18.4 |
% |
Total Run Rate grew 18.4% to $1,899.0 million as of March 31, 2021 compared to $1,604.2 million as of March 31, 2020. Recurring subscriptions Run Rate grew 11.1% to $1,395.8 million as of March 31, 2021 compared to $1,256.0 million as of March 31, 2020. Adjusting for the impact of foreign currency exchange rate fluctuations, recurring subscriptions Run Rate would have increased 10.3% as of March 31, 2021 compared to March 31, 2020.
Run Rate from asset-based fees increased 44.5% to $503.2 million as of March 31, 2021 from $348.2 million as of March 31, 2020, primarily driven by higher AUM in ETFs linked to MSCI equity indexes, higher prices in non-ETF indexed funds linked to MSCI indexes and higher prices in futures and options. Partially offsetting the impact of the increase in AUM in ETFs linked to MSCI equity indexes was a change in fee levels of certain products, which was the primary driver of a decline in average basis point fees to 2.61 as of March 31, 2021 from 2.71 as of March 31, 2020. As of March 31, 2021, the value of AUM in ETFs linked to MSCI equity indexes was $1,209.6 billion, up $500.1 billion, or 70.5%, from $709.5 billion as of March 31, 2020. The increase of $500.1 billion consisted of market appreciation of $353.3 billion and net inflows of $146.8 billion.
Index recurring subscriptions Run Rate grew 10.5% to $634.6 million as of March 31, 2021 compared to $574.1 million as of March 31, 2020, primarily driven by growth in market cap-weighted index products and reflected growth across all regions and all client segments.
Run Rate from Analytics products increased 5.4% to $557.0 million as of March 31, 2021 compared to $528.4 million as of March 31, 2020, primarily driven by growth in both Multi-Asset Class and Equity Analytics products. Adjusting for the impact of foreign currency exchange rate fluctuations, Analytics Run Rate would have increased 4.7% as of March 31, 2021.
Run Rate from ESG and Climate products increased 42.0% to $147.3 million as of March 31, 2021 compared to $103.8 million as of March 31, 2020, primarily driven by strong growth in both Ratings and Climate products. Adjusting for the impact of foreign currency exchange rate fluctuations, ESG and Climate Run Rate would have increased 38.8% as of March 31, 2021 compared to March 31, 2020.
Run Rate from All Other – Private Assets products increased 14.6% to $56.9 million as of March 31, 2021 compared to $49.7 million as of March 31, 2020, primarily driven by strong growth in both Enterprise Analytics and Global Intel products and growth from new sales of Real Estate Climate Value-at-Risk products. Adjusting for the impact of foreign currency exchange rate fluctuations, All Other – Private Assets Run Rate would have increased 7.4% as of March 31, 2021 compared to March 31, 2020.
Sales
Sales represents the annualized value of products and services clients commit to purchase from MSCI and will result in additional operating revenues. Non-recurring sales represent the actual value of the customer agreements entered into during the period and are not a component of Run Rate. New recurring subscription sales represent additional selling activities, such as new customer agreements, additions to existing agreements or increases in price that occurred during the period and are additions to Run Rate. Subscription cancellations reflect client activities during the period, such as discontinuing products and services and/or reductions in price, resulting in reductions to Run Rate. Net new recurring subscription sales represent the amount of new recurring subscription sales net of subscription cancellations during the period, which reflects the net impact to Run Rate during the period.
31
Total gross sales represent the sum of new recurring subscription sales and non-recurring sales. Total net sales represent the total gross sales net of the impact from subscription cancellations.
The following table presents our recurring subscription sales, cancellations and non-recurring sales by reportable segment for the periods indicated:
|
Three Months Ended |
|
|
|
|
|
|||||
|
March 31, |
|
|
March 31, |
|
|
% |
|
|||
|
2021 |
|
|
2020 |
|
|
Change |
|
|||
|
(in thousands) |
|
|||||||||
New recurring subscription sales |
|
|
|
|
|
|
|
|
|
|
|
Index |
$ |
20,856 |
|
|
$ |
19,054 |
|
|
|
9.5 |
% |
Analytics |
|
12,210 |
|
|
|
11,218 |
|
|
|
8.8 |
% |
ESG and Climate |
|
11,640 |
|
|
|
6,994 |
|
|
|
66.4 |
% |
All Other - Private Assets |
|
1,684 |
|
|
|
1,175 |
|
|
|
43.3 |
% |
New recurring subscription sales total |
|
46,390 |
|
|
|
38,441 |
|
|
|
20.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
Subscription cancellations |
|
|
|
|
|
|
|
|
|
|
|
Index |
|
(5,198 |
) |
|
|
(5,116 |
) |
|
|
1.6 |
% |
Analytics |
|
(5,879 |
) |
|
|
(8,244 |
) |
|
|
(28.7 |
%) |
ESG and Climate |
|
(1,052 |
) |
|
|
(1,503 |
) |
|
|
(30.0 |
%) |
All Other - Private Assets |
|
(698 |
) |
|
|
(550 |
) |
|
|
26.9 |
% |
Subscription cancellations total |
|
(12,827 |
) |
|
|
(15,413 |
) |
|
|
(16.8 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
Net new recurring subscription sales |
|
|
|
|
|
|
|
|
|
|
|
Index |
|
15,658 |
|
|
|
13,938 |
|
|
|
12.3 |
% |
Analytics |
|
6,331 |
|
|
|
2,974 |
|
|
|
112.9 |
% |
ESG and Climate |
|
10,588 |
|
|
|
5,491 |
|
|
|
92.8 |
% |
All Other - Private Assets |
|
986 |
|
|
|
625 |
|
|
|
57.8 |
% |
Net new recurring subscription sales total |
|
33,563 |
|
|
|
23,028 |
|
|
|
45.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
Non-recurring sales |
|
|
|
|
|
|
|
|
|
|
|
Index |
|
11,205 |
|
|
|
10,283 |
|
|
|
9.0 |
% |
Analytics |
|
2,973 |
|
|
|
3,265 |
|
|
|
(8.9 |
%) |
ESG and Climate |
|
697 |
|
|
|
151 |
|
|
|
361.6 |
% |
All Other - Private Assets |
|
886 |
|
|
|
880 |
|
|
|
0.7 |
% |
Non-recurring sales total |
|
15,761 |
|
|
|
14,579 |
|
|
|
8.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
Gross sales |
|
|
|
|
|
|
|
|
|
|
|
Index |
$ |
32,061 |
|
|
$ |
29,337 |
|
|
|
9.3 |
% |
Analytics |
|
15,183 |
|
|
|
14,483 |
|
|
|
4.8 |
% |
ESG and Climate |
|
12,337 |
|
|
|
7,145 |
|
|
|
72.7 |
% |
All Other - Private Assets |
|
2,570 |
|
|
|
2,055 |
|
|
|
25.1 |
% |
Total gross sales |
$ |
62,151 |
|
|
$ |
53,020 |
|
|
|
17.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
|
|
|
|
|
|
|
|
|
|
Index |
$ |
26,863 |
|
|
$ |
24,221 |
|
|
|
10.9 |
% |
Analytics |
|
9,304 |
|
|
|
6,239 |
|
|
|
49.1 |
% |
ESG and Climate |
|
11,285 |
|
|
|
5,642 |
|
|
|
100.0 |
% |
All Other - Private Assets |
|
1,872 |
|
|
|
1,505 |
|
|
|
24.4 |
% |
Total net sales |
$ |
49,324 |
|
|
$ |
37,607 |
|
|
|
31.2 |
% |
32
A significant portion of MSCI's operating revenues are derived from subscriptions or licenses of products and services, which are provided over contractually-agreed periods of time that are subject to renewal or cancellation at the end of current contract terms.
Retention Rate
The following table presents our Retention Rate by reportable segment for the periods indicated:
|
Three Months Ended |
|
|||||
|
March 31, |
|
|||||
|
|
2021 |
|
|
|
2020 |
|
Index |
96.6% |
|
|
96.3% |
|
||
Analytics |
95.8% |
|
|
93.7% |
|
||
ESG and Climate |
97.0% |
|
|
94.1% |
|
||
All Other - Private Assets |
95.1% |
|
|
95.7% |
|
||
|
|
|
|
|
|
|
|
Total |
96.3% |
|
|
95.0% |
|
The annual Retention Rate represents the retained subscription Run Rate (subscription Run Rate at the beginning of the fiscal year less actual cancels during the year) as a percentage of the subscription Run Rate at the beginning of the fiscal year. Retention Rate is an important metric because subscription cancellations decrease our Run Rate and ultimately our future operating revenues over time.
The Retention Rate for a non-annual period is calculated by annualizing the cancellations for which we have received a notice of termination or for which we believe there is an intention not to renew during the non-annual period, and we believe that such notice or intention evidences the client’s final decision to terminate or not renew the applicable agreement, even though such notice is not effective until a later date. This annualized cancellation figure is then divided by the subscription Run Rate at the beginning of the fiscal year to calculate a cancellation rate. This cancellation rate is then subtracted from 100% to derive the annualized Retention Rate for the period.
Retention Rate is computed by operating segment on a product/service-by-product/service basis. In general, if a client reduces the number of products or services to which it subscribes within a segment, or switches between products or services within a segment, we treat it as a cancellation for purposes of calculating our Retention Rate except in the case of a product or service switch that management considers to be a replacement product or service. In those replacement cases, only the net change to the client subscription, if a decrease, is reported as a cancel. In the Analytics and the ESG and Climate operating segments, substantially all product or service switches are treated as replacement products or services and netted in this manner, while in our Index and Real Estate operating segments, product or service switches that are treated as replacement products or services and receive netting treatment occur only in certain limited instances. In addition, we treat any reduction in fees resulting from a down-sell of the same product or service as a cancellation to the extent of the reduction. We do not calculate Retention Rate for that portion of our Run Rate attributable to assets in index-linked investment products or futures and options contracts, in each case, linked to our indexes.
Retention Rate is generally higher during the first three quarters and lower in the fourth quarter, as the fourth quarter is traditionally the largest renewal period in the year.
Critical Accounting Policies and Estimates
We describe our significant accounting policies in Note 1, “Introduction and Basis of Presentation,” of the Notes to Consolidated Financial Statements included in our Form 10-K. There have been no significant changes in our accounting policies or critical accounting estimates since the end of the fiscal year ended December 31, 2020.
Liquidity and Capital Resources
We require capital to fund ongoing operations, internal growth initiatives and acquisitions. Our primary sources of liquidity are cash flows generated from our operations, existing cash and cash equivalents and credit capacity under our existing credit facility. In addition, we believe we have access to additional funding in the public and private markets. We intend to use these sources of liquidity to, among other things, service our existing and future debt obligations, fund our working capital requirements for capital expenditures, investments, acquisitions and dividend payments, and repurchases of our common stock. In connection with our business strategy, we regularly evaluate acquisition and strategic partnership opportunities. We believe our liquidity, along with other financing alternatives, will provide the necessary capital to fund these transactions and achieve our planned growth.
33
Senior Notes and Credit Agreement
We have an aggregate of $3,900.0 million in Senior Notes outstanding and a $500.0 million undrawn Revolving Credit Agreement with a syndicate of banks. On April 12, 2021, we paid $518.2 million, which included a premium of $18.2 million, for the pre-maturity redemption all of the outstanding 2026 Senior Notes. See Note 7, “Commitments and Contingencies,” of the Notes to Condensed Consolidated Financial Statements (Unaudited) included herein for additional information on our Senior Notes and Revolving Credit Agreement.
The Senior Notes and the Revolving Credit Agreement are fully and unconditionally, and jointly and severally, guaranteed by our direct or indirect wholly owned domestic subsidiaries that account for more than 5% of our and our subsidiaries’ consolidated assets, other than certain excluded subsidiaries (the “subsidiary guarantors”). Amounts due under the Revolving Credit Agreement are our and the subsidiary guarantors’ senior unsecured obligations and rank equally with the Senior Notes and any of our other unsecured, unsubordinated debt, senior to any of our subordinated debt and effectively subordinated to our secured debt to the extent of the assets securing such debt.
The indentures governing our Senior Notes (the “Indentures”) among us, each of the subsidiary guarantors, and Wells Fargo Bank, National Association, as trustee, contain covenants that limit our and certain of our subsidiaries’ ability to, among other things, incur liens, enter into sale/leaseback transactions and consolidate, merge or sell all or substantially all of our assets. In addition, the Indentures restrict our non-guarantor subsidiaries’ ability to create, assume, incur or guarantee additional indebtedness without such non-guarantor subsidiaries guaranteeing the Senior Notes on a pari passu basis.
The Revolving Credit Agreement contains affirmative and restrictive covenants that, among other things, limit our ability and the ability of our existing or future subsidiaries to:
|
• |
incur liens; |
|
• |
in the case of our subsidiaries that are not guarantors under the Revolving Credit Agreement, incur additional indebtedness; |
|
• |
merge, dissolve, liquidate, consolidate with or into another person or sell all or substantially all assets of the Company and its subsidiaries on a consolidated basis; |
|
• |
enter into sale/leaseback transactions; |
|
• |
pay dividends or make other distributions in respect of our capital stock or engage in stock repurchases, redemptions and other restricted payments; or |
|
• |
change the nature of our business. |
The Revolving Credit Agreement and the Indentures also contain customary events of default, including those relating to non-payment, breach of representations, warranties or covenants, cross-default and cross-acceleration, and bankruptcy and insolvency events, and, in the case of the Revolving Credit Agreement, invalidity or impairment of loan documentation, change of control and customary ERISA defaults in addition to the foregoing. None of the restrictions above are expected to impact our ability to effectively operate the business.
The Revolving Credit Agreement also requires us and our subsidiaries to achieve financial and operating results sufficient to maintain compliance with the following financial ratios on a consolidated basis through the termination of the Revolving Credit Agreement: (1) the maximum Consolidated Leverage Ratio (as defined in the Revolving Credit Agreement) measured quarterly on a rolling four-quarter basis shall not exceed 4.25:1.00 (or 4.50:1.00 for two fiscal quarters following a material acquisition) and (2) the minimum Consolidated Interest Coverage Ratio (as defined in the Revolving Credit Agreement) measured quarterly on a rolling four-quarter basis shall be at least 4.00:1.00. As of March 31, 2021, our Consolidated Leverage Ratio was 3.53:1.00 and our Consolidated Interest Coverage Ratio was 7.57:1.00. As of March 31, 2021, there were no amounts drawn and outstanding under the Revolving Credit Agreement.
34
Our non-guarantor subsidiaries under the Senior Notes consist of: (i) domestic subsidiaries of the Company that account for 5% or less of consolidated assets of the Company and its subsidiaries and (ii) any foreign or domestic subsidiary of the Company that is deemed to be a controlled foreign corporation within the meaning of Section 957 of the Internal Revenue Code of 1986, as amended. Our non-guarantor subsidiaries accounted for approximately $1,035.4 million, or 58.9%, of our total revenue for the trailing 12 months ended March 31, 2021, approximately $375.2 million, or 40.3%, of our consolidated operating income for the trailing 12 months ended March 31, 2021, and approximately $1,058.0 million, or 23.2%, of our consolidated total assets (excluding intercompany assets) and $688.3 million, or 13.6%, of our consolidated total liabilities, in each case as of March 31, 2021.
Share Repurchases
The following table provides information with respect to repurchases of the Company’s common stock pursuant to open market repurchases:
Three Months Ended |
|
Average Price Paid Per Share |
|
|
Total Number of Shares Repurchased |
|
|
Dollar Value of Shares Repurchased |
|
|||
|
|
|
|
|
|
(in thousands) |
|
|||||
March 31, 2021 |
|
$ |
407.70 |
|
|
|
330 |
|
|
$ |
134,340 |
|
March 31, 2020 |
|
$ |
248.65 |
|
|
|
1,310 |
|
|
$ |
325,699 |
|
As of March 31, 2021, there was $1,594.4 million of available authorization remaining under the 2020 Repurchase Program.
Cash Dividend
On April 26, 2021, the Board of Directors declared a quarterly cash dividend of $0.78 per share for the three months ending June 30, 2021. The second quarter 2021 dividend is payable on May 28, 2021 to shareholders of record as of the close of trading on May 14, 2021.
Cash Flows
|
|
As of |
|
|||||
|
|
March 31, |
|
|
December 31, |
|
||
|
|
|
2021 |
|
|
|
2020 |
|
|
|
(in thousands) |
|
|||||
Cash and cash equivalents |
|
$ |
1,747,147 |
|
|
$ |
1,300,521 |
|
Cash and cash equivalents were $1,747.1 million and $1,300.5 million as of March 31, 2021 and December 31, 2020, respectively. We typically seek to maintain minimum cash balances globally of approximately $200.0 million to $250.0 million for general operating purposes. As of March 31, 2021 and December 31, 2020, $473.7 million and $423.3 million, respectively, of the cash and cash equivalents were held by foreign subsidiaries. Repatriation of some foreign cash may be subject to certain withholding taxes in local jurisdictions and other distribution restrictions. The global cash and cash equivalent balances that are maintained will be available to meet our global needs whether for general corporate purposes or other needs, including acquisitions or expansion of our products.
We believe that global cash flows from operations, together with existing cash and cash equivalents and funds available under our existing credit facility and our ability to access the debt and capital markets for additional funds, will continue to be sufficient to fund our global operating activities and cash commitments for investing and financing activities, such as material capital expenditures and share repurchases, for at least the next 12 months and for the foreseeable future thereafter. In addition, we expect that foreign cash flows from operations, together with existing cash and cash equivalents will continue to be sufficient to fund our foreign operating activities and cash commitments for investing activities, such as material capital expenditures, for at least the next 12 months and for the foreseeable future thereafter.
35
Net Cash Provided by (Used In) Operating, Investing and Financing Activities
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
|
|
|
2021 |
|
|
2020 |
|
|
|
|
(in thousands) |
|
|||||
Net cash provided by operating activities |
|
$ |
215,457 |
|
|
$ |
112,770 |
|
Net cash used in investing activities |
|
|
(10,360 |
) |
|
|
(201,638 |
) |
Net cash provided by (used in) financing activities |
|
|
245,542 |
|
|
|
(340,081 |
) |
Effect of exchange rate changes |
|
|
(4,013 |
) |
|
|
(10,762 |
) |
Net increase (decrease) in cash |
|
$ |
446,626 |
|
|
$ |
(439,711 |
) |
Cash Flows From Operating Activities
Cash flows from operating activities consist of net income adjusted for certain non-cash items and changes in assets and liabilities. Cash provided by operating activities was $215.5 million and $112.8 million for the three months ended March 31, 2021 and 2020, respectively. The year-over-year increase was primarily driven by higher cash collections from customers.
Our primary uses of cash from operating activities are for the payment of cash compensation expenses, office rent, technology costs, market data costs, interest expenses and income taxes. Historically, the payment of cash for compensation and benefits is at its highest level in the first quarter when we pay discretionary employee compensation related to the previous fiscal year.
Cash Flows From Investing Activities
Cash used in investing activities was $10.4 million for the three months ended March 31, 2021 compared to $201.6 million for the three months ended March 31, 2020. The year-over-year change was primarily driven by the absence of the $190.8 million equity method investment in Burgiss.
Cash Flows From Financing Activities
Cash provided by financing activities was $245.5 million for the three months ended March 31, 2021 compared to cash used in financing activities of $340.1 million for the three months ended March 31, 2020. The year-over-year change was primarily driven by the absence of the 2024 Senior Notes Redemption, lower share repurchases and the impact of higher proceeds from the new senior notes offerings made during the three months ended March 31, 2021.
Off-Balance Sheet Arrangements
We do not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.
Item 3. |
Quantitative and Qualitative Disclosures about Market Risk |
Foreign Currency Risk
We are subject to foreign currency exchange fluctuation risk. Exchange rate movements can impact the U.S. dollar-reported value of our revenues, expenses, assets and liabilities denominated in non-U.S. dollar currencies or where the currency of such items is different than the functional currency of the entity where these items were recorded.
We generally invoice our clients in U.S. dollars; however, we invoice a portion of our clients in Euros, British pounds sterling, Japanese yen and a limited number of other non-U.S. dollar currencies. For the three months ended March 31, 2021 and 2020, 15.0% and 14.0%, respectively, of our revenues are subject to foreign currency exchange rate risk and primarily includes clients billed in foreign currency as well as U.S. dollar exposures on non-U.S. dollar foreign operating entities. Of the 15.0% of non-U.S. dollar exposure for the three months ended March 31, 2021, 40.9% was in Euros, 24.8% was in British pounds sterling and 24.7% was in Japanese yen. Of the 14.0% of non-U.S. dollar exposure for the three months ended March 31, 2020, 38.9% was in Euros, 26.6% was in Japanese yen and 23.3% was in British pounds sterling.
36
Revenues from asset-based fees represented 26.5% and 24.0% of operating revenues for the three months ended March 31, 2021 and 2020, respectively. While a substantial portion of our asset-based fees are invoiced in U.S. dollars, the fees are based on the assets in investment products, of which more than three-fifths are invested in securities denominated in currencies other than the U.S. dollar. Accordingly, declines in such other currencies against the U.S. dollar will decrease the fees payable to us under such licenses. In addition, declines in such currencies against the U.S. dollar could impact the attractiveness of such investment products resulting in net fund outflows, which would further reduce the fees payable under such licenses.
We are exposed to additional foreign currency risk in certain of our operating costs. Approximately 42.7% and 41.3% of our operating expenses for the three months ended March 31, 2021 and 2020, respectively, were denominated in foreign currencies, the significant majority of which were denominated in British pounds sterling, Indian rupees, Hungarian forints, Euros, Swiss francs, Hong Kong dollars and Mexican pesos. Expenses incurred in foreign currency may increase as we expand our business outside the U.S.
We have certain monetary assets and liabilities denominated in currencies other than local functional amounts and when these balances are remeasured into their local functional currency, either a gain or a loss results from the change of the value of the functional currency as compared to the originating currencies. We manage foreign currency exchange rate risk, in part, through the use of derivative financial instruments comprised principally of forward contracts on foreign currency which are not designated as hedging instruments for accounting purposes. The objective of the derivative instruments is to minimize the impact on the income statement of the volatility of amounts denominated in certain foreign currencies. We recognized total foreign currency exchange losses of $0.6 million and gains of $1.9 million for the three months ended March 31, 2021 and 2020, respectively.
Item 4. |
Controls and Procedures |
Our Chief Executive Officer and Chief Financial Officer have evaluated our disclosure controls and procedures, as defined in Rule 13a-15(e) or 15d-15(e) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”), as of March 31, 2021, and have concluded that these disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time specified in the SEC’s rules and forms. These disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.
There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended March 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
37
PART II – OTHER INFORMATION
Item 1. |
Legal Proceedings |
Various lawsuits, claims and proceedings have been or may be instituted or asserted against the Company in the ordinary course of business. While the amounts claimed could be substantial, the ultimate liability cannot now be determined because of the considerable uncertainties that exist. Therefore, it is possible that MSCI’s business, operating results, financial condition or cash flows in a particular period could be materially affected by certain contingencies. However, based on facts currently available, management believes that the disposition of matters that are currently pending or asserted will not, individually or in the aggregate, have a material effect on MSCI’s business, operating results, financial condition or cash flows.
Item 1A. |
Risk Factors |
There have been no material changes to the significant risk factors and uncertainties known to the Company and disclosed in the Company’s Form 10-K for the fiscal year ended December 31, 2020 that, if they were to materialize or occur, would, individually or in the aggregate, have a material effect on MSCI’s business, operating results, financial condition or cash flows.
For a discussion of the risk factors affecting the Company, see “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for fiscal year 2020.
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds |
There have been no unregistered sales of equity securities.
The table below presents information with respect to purchases made by or on behalf of the Company of its common shares during the three months ended March 31, 2021.
Issuer Purchases of Equity Securities
Period |
|
Total Number of Shares Purchased(1) |
|
|
Average Price Paid Per Share |
|
|
Total Number of Shares Purchased As Part of Publicly Announced Plans or Programs |
|
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(2) |
|
||||
January 1, 2021-January 31, 2021 |
|
|
719 |
|
|
$ |
446.43 |
|
|
|
— |
|
|
$ |
1,728,753,000 |
|
February 1, 2021-February 28, 2021 |
|
|
121,941 |
|
|
$ |
429.57 |
|
|
|
— |
|
|
$ |
1,728,753,000 |
|
March 1, 2021-March 31, 2021 |
|
|
329,772 |
|
|
$ |
407.71 |
|
|
|
329,508 |
|
|
$ |
1,594,416,000 |
|
Total |
|
|
452,432 |
|
|
$ |
413.66 |
|
|
|
329,508 |
|
|
$ |
1,594,416,000 |
|
(1) |
Includes (i) shares purchased by the Company on the open market under the stock repurchase program; (ii) shares withheld to satisfy tax withholding obligations on behalf of employees that occur upon vesting and delivery of outstanding shares underlying restricted stock units; (iii) shares withheld to satisfy tax withholding obligations and exercise price on behalf of employees that occur upon exercise and delivery of outstanding shares underlying stock options; and (iv) shares held in treasury under the MSCI Inc. Non-Employee Directors Deferral Plan. The value of shares withheld to satisfy tax withholding obligations was determined using the fair market value of the Company’s common stock on the date of withholding, using a valuation methodology established by the Company. |
(2) |
See Note 9, “Shareholders’ Equity (Deficit)” of the Notes to the Unaudited Condensed Consolidated Financial Statements included herein for further information regarding our stock repurchase program. |
38
Item 6. |
Exhibits |
EXHIBIT INDEX
|
|
Exhibit Number |
|
Description |
|
|
|
||
|
|
3.1 |
|
|
|
|
|
|
|
|
|
3.2 |
|
|
|
|
4.1 |
|
|
|
|
|
|
|
|
|
10.1 |
|
|
|
|
|
|
|
|
|
|
||
* |
|
10.2† |
|
Employment Letter, entered into on April 27, 2021, between MSCI Inc. and C.D. Baer Pettit.
|
|
|
11 |
|
Statement Re: Computation of Earnings Per Common Share (The calculation of per share earnings is in Part I, Item 1, Note 4 to the Condensed Consolidated Financial Statements (Earnings Per Common Share) and is omitted in accordance with Section (b)(11) of Item 601 of Regulation S-K) |
|
|
|
|
|
* |
|
31.1 |
|
|
|
|
|
|
|
* |
|
31.2 |
|
|
|
|
|
|
|
** |
|
32.1 |
|
Section 1350 Certification of the Chief Executive Officer and the Chief Financial Officer |
|
|
|
|
|
|
|
|
||
* |
|
101.INS |
|
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
|
|
|
|
|
* |
|
101.SCH |
|
Inline XBRL Taxonomy Extension Schema Document |
|
|
|
|
|
* |
|
101.CAL |
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document |
|
|
|
|
|
* |
|
101.LAB |
|
Inline XBRL Taxonomy Extension Label Linkbase Document |
|
|
|
|
|
* |
|
101.PRE |
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document |
|
|
|
|
|
* |
|
101.DEF |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document |
|
|
|
|
|
* |
|
104 |
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
|
|
|||
* |
|
Filed herewith. |
||
** |
|
Furnished herewith.
|
||
† |
|
Indicates a management compensation plan, contract or arrangement.
|
39
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Dated: April 28, 2021
|
MSCI INC. (Registrant) |
|
|
|
|
|
By: |
/s/ Andrew C. Wiechmann |
|
|
Andrew C. Wiechmann Chief Financial Officer (Principal Financial Officer) |
40
Exhibit 10.2
April 27, 2021
Private and Confidential
C.D. Baer Pettit
[ADDRESS]
Dear Baer,
Confirmation of the terms and conditions of your employment with MSCI Limited (the “Company”).
Further to recent communications, this letter is, subject to approval by the Board of Directors of MSCI Inc., intended to confirm the terms of your employment with the Company in the position of Managing Director, President and Chief Operating Officer. In this position, you are a member of the Firm’s Executive Committee and report directly to Henry Fernandez, Chairman and Chief Executive Officer.
This letter is intended to take effect as a deed and supersedes and extinguishes all previous agreements between you and the Company in relation to your terms and conditions of employment.
This letter should be read in conjunction with the Employee Handbook (Parts One and Two) and the MSCI Code of Conduct which, together with this letter, form the terms and conditions of your employment.
Notwithstanding the fact that you are employed by the Company, your employment may be seconded to whatever company in the MSCI group of companies (collectively, “MSCI Group” or “MSCI”) within the UK as the Company may from time to time determine.
Continuous employment
Your continuous employment with the Company began on January 24, 2000.
Notwithstanding the above, the Company may terminate your employment at any time without notice or payment in lieu of notice if you commit an act of gross misconduct or a serious breach of your obligations or if you cease to be entitled to work in the United Kingdom.
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
Compensation
Your annualized total target compensation consists of the following components:
Base Salary: Effective January 1, 2021, your annualised base salary shall be £625,000 and paid in monthly instalments on or about the 26th day of each month directly into your bank account, net of any tax and national insurance as appropriate, under the PAYE system. Your annualised base salary for subsequent years will be confirmed to you separately.
Annual Incentive Plan: You are eligible to participate in the Company’s Annual Incentive Plan (AIP) with a bonus target of £900,000 for the year ending December 31, 2021. Your target bonus for subsequent years will be confirmed to you separately. Any bonus payment that may be awarded to you under the AIP will be subject to any tax and national insurance deductions as the Company considers is required by law.
As detailed below, your bonus award under the AIP, if any, will be determined based on your annual performance against the achievement of: (i) company and/or product line financial metrics and (ii) your Key Performance Indicators (KPIs) and leadership effectiveness (including your management engagement score).
|
o |
Company and/or product line financial metrics represent 70% of your overall AIP target bonus. This component of the bonus is non-discretionary and the actual payout is based on the achievement of specific financial metrics. These metrics will be reviewed annually and determined by MSCI in its sole discretion. |
|
o |
KPIs and leadership effectiveness represent 20% of your overall AIP target bonus. This portion of the bonus is based entirely on the discretion of your manager. |
|
o |
Diversity, Equality, and Inclusion goals represent 10% of your overall AIP target bonus. This portion of the bonus is based entirely on the discretion of your manager. |
Bonus awards that you may receive under the AIP may vary significantly from year to year. There is no representation that a bonus award in one year will be comparable to another year. There is no implied term that, if the amount of any bonus award is lower in any subsequent year, MSCI will compensate you for such difference. Under no circumstances is the bonus award under the AIP to be considered part of your base salary or other regular employment income.
From time to time, we review the form and terms of our incentive plans and we reserve the right to amend, change or cancel our plans (or elements thereof) as the Company determines necessary. You will be notified of any material changes by the Company.
Long-Term Incentive Plan (LTIP): You are eligible to receive a discretionary equity award pursuant to MSCI’s Long Term Incentive Plan. LTIP awards, if any, will be made pursuant to the terms of the MSCI Inc. 2016 Omnibus Incentive Plan (as may be amended from time to time) (together with any successor plan thereto, the “Omnibus Plan”) and will be governed by the terms
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
of the Omnibus Plan and the applicable grant agreements thereunder approved by the Board or the Compensation Committee.
You are eligible for an LTIP target award of $4,000,000 for the year ending December 31, 2021. Your target award for subsequent years will be confirmed to you separately. The LTIP target value represents the baseline or starting point for any LTIP awards and your actual award can be more, or less, than the target value. Your LTIP target value is based, in part, on your level and the size and complexity of your role. The LTIP target dollar value will not necessarily change each year. LTIP awards, if any, will be made pursuant to the terms of the applicable plan and are governed by such plan and applicable grant agreements approved by the Board or Compensation Committee. LTIP awards are also subject to and conditional on applicable legal and regulatory requirements to which the MSCI Group is subject from time-to-time.
Any LTIP awards that you may receive from MSCI will contain certain restrictive covenants, including with respect to non-competition, non-solicitation, non-hire, non-disparagement, notice requirements and other restrictions that you must agree to and comply with as a condition of the award, including after any resignation or termination of your employment with MSCI. Attached as Exhibit 1 is an example of restrictive covenants contained in MSCI equity awards.
From time to time, we review the form and terms of our incentive plans and we reserve the right to amend, change or cancel our plans (or elements thereof) as the Company determines necessary. You will be notified of any material changes by the Company.
Bonus Awards, Generally: All bonuses for which you may be eligible, including but not limited to any incentive awards under the AIP, any equity-based award under the Omnibus Plan and/or any other discretionary bonuses, are subject to (i) MSCI’s performance, (ii) your individual performance and conduct in a manner consistent with all MSCI policies and procedures, (iii) you remaining actively employed by the Company and actively providing services to the MSCI Group (and not on any period of paid or unpaid leave) in the period up to the applicable payment date of any incentive award or other discretionary award and/or the grant and vesting dates of any equity award that may be made to you (subject to the terms of the relevant incentive or equity plan rules and unless otherwise provided by applicable law) and (iv) approval by the Compensation and Talent Management Committee (Compensation Committee) of the Company’s Board of Directors (Board). Bonus awards, if any, for a given year (i) may be paid following completion of such year and (ii) are not earned or accrued until the applicable payment date of any incentive award or other discretionary award and/or the grant and vesting dates of any equity award that may be made to you (subject to the terms of the relevant incentive or equity plan rules and unless otherwise provided by applicable law).
Severance Practice
As a member of the Executive Committee, in the event your employment is terminated by the Company for a reason that is not related to your conduct, capability, performance or entitlement to carry out your role (including but not limited to reasons relating to regulatory and/or legal requirements), you will be eligible for a lump sum payment equal to one times the sum of your annual base salary and target AIP bonus, plus, at the Company’s absolute discretion, a prorated
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
AIP bonus for the year of termination based on actual performance in the period up to the date of termination (the “Severance Payment”).
In addition, in the event the Company terminates your employment based on a cause other than gross misconduct, all outstanding LTIP awards will be treated in accordance with, and subject to, the terms set forth in the Omnibus Plan and the applicable grant agreement governing such awards.
Notwithstanding the foregoing, from time to time, we review our severance practices and we reserve the right to amend, change or cancel them (or elements thereof) as the Company determines necessary. You will be notified of any material changes by the Company.
Hours of work
The Company’s normal office hours are 9 a.m. to 5.30 p.m. Mondays to Fridays with an hour for lunch. However, you shall be required to work such additional hours as may be necessary for the proper performance of your duties (and your salary is deemed to include payment for such additional hours).
Place of work
Your principal place of work will be the Company’s premises in London, Ninth Floor, Ten Bishops Square, London, E1 6EG. MSCI has a Future of Work (FOW) policy, which covers role flexibility, under which you may be permitted to work remotely based on business and client priorities, and subject to the rules of the scheme. The policy does not form part of your terms and conditions of employment, and MSCI reserves the right to review, amend or withdraw the scheme at any time. Further details are available from the MSCI Future of Work (FOW) Policy.
You may be required to travel within or outside the UK from time to time, and this may involve travelling outside normal business hours. You will not be required to work continuously outside the UK for periods exceeding one month. Reasonable travel expenses will be reimbursed in accordance with the Company’s expense policy.
Performance of duties
You will, at all times:
|
(a) |
be familiar and comply with the MSCI Code of Conduct and all applicable policies and procedures of the Company and/or the MSCI Group; |
|
(b) |
in relation to responsibilities delegated to you, discharge those responsibilities carefully and in an appropriate manner, in accordance with the MSCI Group’s policies and procedures, any applicable regulatory permissions or approvals, and any other regulatory requirements, including without limitation the FCA’s conduct rules, (as applicable), and ensure that sufficient and prompt information in relation to your performance or further delegation of such responsibilities is provided to your line manager; |
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
|
(c) |
take all reasonable steps to ensure that those who you are required to supervise or to whom you may delegate responsibilities undertake their duties in an appropriate manner in accordance with MSCI Group’s policies and procedures, any applicable regulatory permissions or approvals and any other regulatory requirements, including, without limitation, the FCA’s conduct rules (as applicable) and take all steps which are reasonably necessary to ensure their adequate and continued supervision to comply with such obligations; |
|
(d) |
comply with all rules, requirements, recommendations, regulations or guidance, as amended from time to time, of any regulatory authority which is relevant to your role and/or to the MSCI Group, including, but not limited to, the FCA’s conduct rules as amended from time to time (as applicable); |
|
(e) |
promptly disclose to the Company any wrongdoing or proposed wrongdoing, or breach or suspected breach of any relevant regulatory rules or requirements, including without limitation the FCA’s conduct rules, by any employee, worker, director or other officer of the MSCI Group, including your own wrongdoing, that you may become aware of; |
|
(f) |
complete such training and documentation, fulfill such instructions and provide such information as may reasonably be requested to fulfil any MSCI Group regulatory obligations and in order for you to satisfy the regulatory obligations to which you are or may be subject; and |
|
(g) |
sign any certifications or confirmations which the Company reasonably requires you to sign relating to your personal obligations under any legislation or regulations affecting you in your position as an employee, director or officer of the MSCI Group. |
Employee Warranties & Conditions
It is a condition of your employment that you do not undertake any other paid employment without the express permission of the Company or as otherwise set out in the Employee Handbook or MSCI Code of Conduct. Such permission will not be unreasonably withheld.
Termination of employment
You may terminate your employment by giving the Company written notice to terminate as follows:
|
- |
Executive Committee: 180 days. |
The Company may terminate your employment by giving you written notice to terminate as follows:
|
- |
Executive Committee: 180 days. |
The Company reserves the right, in its absolute discretion, to terminate your employment at any time and with immediate effect by notifying you that it is doing so and that the Company will make
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
a payment in lieu of notice to you. Such payment in lieu of notice will be equal to the basic salary (as at the date of termination) which you would have been entitled to receive under this agreement during the notice period referred to above (or where part of your notice period has been served, the remainder of the notice period) less statutory deductions.
Further details regarding termination of employment and garden leave are set out in section 9 of Part 1 of the Employee Handbook.
Benefits
You will have been enrolled automatically in the MSCI Group Personal Pension Plan from the date you commenced employment unless you confirmed to us that you did not wish to be so. If you have any questions, please contact your local HR representative, Shara Seeyave.
Members who receive a year-end bonus may, at the discretion of the Company, waive part, or all, of the cash component of this into the MSCI Group Personal Pension Plan up to the level of the HMRC allowances. You will receive further information on this as part of the Company’s year-end bonus waiver process.
Subject to the rules of the relevant scheme and if and to the extent that cover is available on normal terms, you are covered by the Company’s Life Assurance, Personal Accident and Disability benefits and are eligible to become a member of the Company’s Medical and Dental Plans.
The above benefit plans are provided at the discretion of the Company, and the Company reserves the right to review, withdraw and amend these plans at any time.
You are entitled to 30 days’ paid annual leave (plus public holidays) during each calendar year. One day's holiday pay is calculated at a rate of 1/261 of full-time salary (pro-rated for part-time employees).
All holiday arrangements must be communicated to your manager no later than 15 working days before the applicable holiday period. Holiday can only be taken by arrangement with your manager. Any holiday with pay taken without prior authorisation shall be treated as unauthorised and may result in disciplinary action or deduction from pay. Regulations 15(1) to 15(4) of the Working Time Regulations 1998 (“Dates on which leave is taken”) shall not apply to your employment.
You will not normally be permitted to take more than two weeks holiday consecutively.
You can carry over 5 unused holiday days per year if approved by your manager and with proper notification to Human Resources. Days carried over must be taken by March 31 of the following year. No payment will be made for leave not taken.
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
The Company reserves the right to require you to take all or part of any outstanding holiday entitlement during any period of notice to terminate your employment, including any period of notice during which you are put on garden leave in accordance with clause 9.6 of the Employee Handbook.
Upon the termination of your employment, you will receive a payment representing the holiday with pay which has accrued up to and including the date of termination, less the amount for holiday already taken during that holiday year. Should you have taken more holiday with pay than the accrued entitlement at the date of termination a sum in respect of the excess taken over the amount accrued shall be deducted from any monies due to you by the Company, to which deduction you hereby irrevocably consent. Any such payments in lieu or deductions will be calculated on the basis that a day's holiday is equal to 1/261 of full-time salary (pro-rated for part-time employees).
Further details about holiday entitlement and holiday pay are set out in section 13 of Part 1 of the Employee Handbook.
Sickness Absence
If you cannot attend work because you are sick or injured, you must comply with the notification and certification requirements of the Company’s sickness absence policy, which is contained in the Employee Handbook. This also contains provisions relating to sick pay.
Other paid leave
The Company’s Maternity, Paternity, Adoption and Parental Leave Policies are available from Human Resources but do not form part of the terms and conditions of your employment.
Compliance
You are subject to, and required to comply with, the MSCI Code of Conduct and the relevant MSCI Group Employee Trading Policy, which set out your obligations concerning compliance in further detail.
You understand and agree that as a condition of employment, unless you are granted a waiver in writing by the Legal & Compliance Department you may be required to transfer any brokerage/securities accounts that you may influence or control to a designated institution for surveillance and review by the MSCI Legal & Compliance Department.
Intellectual Property
For the purposes of this letter the following definitions shall apply:
Intellectual Property Rights means (i) copyrights, moral rights, patents, inventions, discoveries, improvements and innovations, know-how, confidential information as defined in the Code of Conduct, database rights, brands, business names, domain names, and rights in trademarks,
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
service marks and designs (whether registered or unregistered), (ii) applications for registration, and the right to apply for registration, and registrations for any of the same, and any renewals, reissues, extensions, continuations or divisions thereof; (iii) rights to use such assets listed in subparagraphs (i) and (ii) above under licences, consents, orders, statutes or otherwise; and (iv) all other intellectual property rights and equivalent or similar forms of protection now or hereafter existing anywhere in the world.
IP Materials means all documents, software, photographic or graphic works of any type, and other materials in any medium or format which are created by or on behalf of you in the course of performing your obligations under the terms and conditions of your employment and which are protected by or relate to Intellectual Property Rights.
Any Intellectual Property Rights created by you, whether alone or with others, arising in the course of your employment or you performing your obligations under the terms and conditions of your employment, whether or not during working hours or by the use of the facilities of the MSCI Group, shall belong to and vest in the Company, and you shall promptly disclose all such Intellectual Property Rights to the Company.
To the extent that ownership of Intellectual Property Rights does not vest in the Company by operation of law, you hereby assign to the Company your entire right, title and interest in all Intellectual Property Rights which arise in the course of performing your obligations under the terms and conditions of your employment (including all present and future copyright, and copyright revivals and extensions). This assignment shall take effect upon the creation of each of the Intellectual Property Rights but if for any reason this does not occur, you agree that you will hold all such Intellectual Property Rights on trust for the benefit of the Company until such time as it does.
You agree to sign all documents and to do all other acts which the Company requests (at its expense) to enable the Company or its nominee(s) to enjoy the full benefit of these provisions relating to Intellectual Property. This includes joining in any application, which may be made in the Company’s sole name, for registration of any Intellectual Property Rights (such as a patent, trademark or registered design), and assisting the Company in defending and enforcing such rights during and after your employment with the Company (at the Company’s expense).
You may only use the Intellectual Property Rights and IP Materials to perform your obligations under the terms and conditions of your employment, and shall not disclose any Intellectual Property Rights or IP Materials to any third party without the express prior written consent of the Company.
You waive all moral rights in IP Materials to which you may otherwise be entitled under the law of any relevant jurisdiction and which cannot be vested or assigned to the Company. To the extent that any moral rights cannot be waived under the laws of any relevant jurisdiction, you agree that you will not enforce such rights.
You shall immediately transfer to the Company all IP Materials in your possession or under your control when the terms and conditions of your employment expire or terminate for any reason, or
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
at any time when the Company requests. No copies or other record of any IP Materials may be retained by you except with the prior written consent of the Company.
You hereby appoint the Company as your Power of Attorney during your employment or after it has terminated, to do anything and sign or execute any document and generally, to use your name for the purpose of giving the Company the full benefit these provisions relating to Intellectual Property. A certificate in writing signed by any director or the secretary of the Company that any instrument or act falls within the authority conferred by these provisions shall be conclusive evidence that such is the case so far as any third party is concerned.
You understand and accept that the remuneration and benefits provided to you by the Company in accordance with the terms and conditions of your employment constitute sufficient consideration to you for the performance of your obligations in these provisions relating to Intellectual Property including, for the avoidance of doubt, the waiver of or covenant not to assert any moral rights that you may have.
The provisions relating to Intellectual Property, and the rights and obligations of you and the Company contained therein, shall survive expiry or termination of your employment for any reason.
Disciplinary and Grievance Procedures
The Disciplinary and Grievance Procedures which are applicable to your employment are set out in Part 3 of the Employee Handbook. These procedures do not form part of your terms and conditions of employment.
If you wish to appeal against a disciplinary decision, please apply in writing to Human Resources in accordance with the Disciplinary Procedure.
If you wish to raise a grievance, please apply in writing to Human Resources in accordance with the Grievance Procedure.
Collective Agreements
There are no Collective Agreements with any trade union in force that affect your terms and conditions of employment.
General
The terms of this letter and any dispute or claim arising out of it or its subject matter or formation shall be governed by and construed in accordance with the laws of England and Wales. You and the Company each irrevocably agree that the courts of England and Wales shall have exclusive jurisdiction to settle any dispute or clam arising out of or in connection with this letter or its subject matter or formation.
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
Where there is any conflict between the terms of: (i) this letter; and (ii) the Employee Handbook or the Code of Conduct, the terms of this letter shall take precedence.
To indicate your acceptance of the terms and conditions of your employment as set out in this letter, please submit an electronically signed copy of this letter, following which it will be sent to your named witness for signature and submission back to the Human Resources Department. Please note, your named witness must physically witness you signing the contract.
Please contact Shara Seeyave at [EMAIL] should you have any questions.
Yours sincerely,
/s/ Shara L. Seeyave
Shara Seeyave
Executive Director
Human Resources
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
This letter has been executed as a DEED and is delivered and takes effect on the date stated at the beginning of it.
Signed as a DEED by: Baer Pettit
|
/s/ C.D. Baer Pettit________________ |
in the presence of: |
/s/ Lisa Honeyman________________ Signature of witness
|
Witness name: |
Honeyman Lisa____________________ |
Witness address: |
[ADDRESS]________________________ ___________________________________ ___________________________________ ___________________________________ |
Witness occupation: |
[OCCUPATION]____________________ |
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
EXHIBIT 1
RESTRICTIVE COVENANTS
All LTIP participants are subject to the provisions of this Exhibit 1, as may be applicable to them pursuant to an MSCI equity award agreement. Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to them in the applicable MSCI equity award agreement.
Section 1.Confidential Information; Assignment of Inventions.
(a)During your employment or service with the Company and at all times thereafter, you agree to keep secret and retain in strictest confidence and trust for the sole benefit of the Company, and shall not disclose, directly or indirectly, or use for your benefit or the benefit of others, without the prior written consent of the Company, any Confidential Information.
(b)In the event of a termination of your employment or service with the Company for any reason, you shall deliver to MSCI all documents and data containing or pertaining to the Confidential Information and shall not retain or take with you any documents or data of any kind or any reproductions (in whole or in part) or extracts of any items containing or relating to the Confidential Information. Nothing contained in this Section 1 of this Exhibit 1 shall prohibit you from disclosing Confidential Information if such disclosure is required by law, governmental process or valid legal process.
(c)Unless you are reporting a possible violation of law to a governmental entity or law enforcement, making a disclosure that is protected under the whistleblower protections of applicable law and/or participating in a governmental investigation, in the event that you are legally compelled to disclose any of the Confidential Information, you shall provide MSCI with prompt written notice so that MSCI, at its sole cost and expense, may seek a protective order or other appropriate remedy or waive compliance with the provisions of this Section 1 of this Exhibit 1. If such protective order or other remedy is not obtained, or if the Company waives compliance with the provisions of this Section 1, you shall furnish only that portion of the Confidential Information that you in good faith believe is legally required to be disclosed. In addition to the foregoing, and subject to the second preceding sentence, you hereby agree to comply with the requirements of any and all agreements that you have entered into, or may in the future enter into, with the Company with respect to the use or disclosure of any of the Confidential Information.
(d)All Inventions shall be the exclusive property of the Company, and you hereby irrevocably assign all right, title and interest in and to all Inventions to the Company. You shall promptly disclose all Inventions to the Company, shall execute at the request of the Company any assignments or other documents that the Company may deem necessary to protect or perfect the rights of the Company therein, and shall assist the Company, at the Company’s expense, in obtaining, defending and enforcing the Company’s rights therein. You hereby appoint the Company as your attorney-in-fact to execute on your behalf any assignments or other documents deemed necessary by the Company to protect or perfect its rights to any Inventions.
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
Section 2.Non-Compete. During your employment or service with the Company and for a period of one year following the termination of your employment or service with the Company for any reason (the “Non-Compete Restricted Period”), you shall not, without the consent of the Company, directly or indirectly, provide services to, accept employment with, be a consultant or advisor to, form, lend financial support to, own any interest in (other than shares of a publicly traded company that represent less than 1% of the outstanding shares) or otherwise enter into any arrangement with, or engage in any activity for or on behalf of, any Competitor (as defined below). Notwithstanding the foregoing, you shall not be in violation of this Section 2 following the termination of your employment or service with the Company to the extent that you provide Permitted Services to a Permitted Business (in each case, as defined below).
Section 3.Non-Solicit and No-Hire. During your employment or service with the Company and for a period of two years following the termination of your employment or service with the Company for any reason (the “Non-Solicit Restricted Period”), you shall not, directly or indirectly, (a) solicit or encourage any employee of the Company to terminate his or her employment with the Company, (b) hire any employee of the Company prior to the date on which such person has not been employed by the Company or any of its Subsidiaries for a period of at least one year or (c) induce or attempt to induce any customer, client, supplier, vendor, licensee or other business relationship of the Company to cease doing or reduce their business with the Company, or in any way interfere with the relationship between the Company and any customer, client, supplier, licensee or other business relationship of the Company.
Section 4.Non-Disparagement. At all times during your employment or service with the Company and after termination of your employment or service with the Company for any reason, you will not knowingly make any statement, written or oral, that would disparage the business or reputation of the Company or its officers, managers, directors or employees. It will not be a violation of this Section 4 for you to make truthful statements, under oath, as required by law, to a governmental or regulatory entity or law enforcement agency or as part of a litigation or administrative agency proceeding.
Section 5.Certain Remedies. You acknowledge that the terms of this Exhibit 1 are reasonable and necessary in light of your unique position, responsibility and knowledge of the operations of the Company and the unfair advantage that your knowledge and expertise concerning the business of the Company would afford a competitor of the Company and are not more restrictive than necessary to protect the legitimate interests of the Company. If the final judgment of a court of competent jurisdiction, or any final non-appealable decision of an arbitrator in connection with a mandatory arbitration, declares that any term or provision of this Exhibit 1 or the Award Agreement is invalid or unenforceable, the parties agree that the court or arbitrator making the determination of invalidity or unenforceability shall have the power to reduce the scope, duration, or geographic area of the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Exhibit 1 and the Award Agreement shall be enforceable as so modified after the expiration of the time within which the judgment or decision may be appealed. You acknowledge that the Company and its shareholders would be irreparably harmed by any breach of this Exhibit 1 and that there would be no adequate remedy at law or in damages to compensate the Company and its shareholders for any such breach. You agree that MSCI shall be entitled to
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
injunctive relief, without having to post bond or other security, requiring specific performance by you of your obligations in this Exhibit 1 in addition to any other remedy to which the Company is entitled at law or in equity, and you consent to the entry thereof. You agree that the Non-Compete Restricted Period and the Non-Solicit Restricted Period, as applicable, shall be extended by any and all periods during which you are in breach of this Exhibit 1.
Section 6.Definitions. For purposes of this Exhibit 1 and the Award Agreement, the following terms shall have the following meanings:
“Competitor” means any person, entity or business that is engaged in, or that owns a significant equity, voting, financial or other interest in an entity that is engaged in, one or more Competing Businesses.
“Competing Business” means any business or activity that competes with the MSCI Business or is reasonably anticipated to compete with the MSCI Business.
“Confidential Information” means all proprietary or confidential matters or trade secrets of, and confidential and competitively valuable information concerning, the Company (whether or not such information is in written form and whether or not its marked confidential). Without limiting the generality of the foregoing, Confidential Information shall include: information concerning organization and operations, business and affairs; formulae, processes, technical data; “know-how”; flow charts; computer programs and computer software; access codes or other systems of information; algorithms; technology and business processes; business, product or marketing plans or strategies; sales and other forecasts; financial information or financing/financial projections; lists of clients or customers or potential clients or customers; details of client or consultant contracts; supplier or vendor lists or arrangements; business acquisition or disposition plans; employee information, new personnel acquisition plans and information relating to compensation and benefits; budget information and procedures; research products; research and development; all data, concepts, ideas, findings, discoveries, developments, programs, designs, inventions, improvements, methods, practices and techniques, whether or not patentable, relating to present or planned future activities or products or services; and public information that becomes proprietary as a result of the Company’s compilation of that information for use in its business; provided, however, that the Confidential Information shall in no event include (x) any Confidential Information which was generally available to the public at the time of disclosure by you or (y) any Confidential Information which becomes publicly available other than as a consequence of the breach by you of your confidentiality obligations hereunder or under any other confidentiality agreement you have entered into with the Company, including, but not limited, the MSCI Code of Ethics and Business Conduct.
“Inventions” means, collectively, all rights to discoveries, inventions, improvements and innovations, copyright and copyrightable materials (including all data and records pertaining thereto) related to the business of the Company, whether or not patentable, copyrightable, registrable as a trademark or reduced to writing, that you may discover, invent or originate during your employment or service with the Company or any predecessor entity, either alone or with others and whether or not during working hours or by the use of the facilities of the Company.
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
“MSCI Business” means any business, or part thereof, engaged in, contemplated or actively planned by the Company as of the date of your termination of employment that you were actively involved in, provided services to, or participated in the planning of, during your employment with the Company.
“Permitted Business” means (i) any Competing Business of the applicable Competitor that is (A) an immaterial part of the overall business of the applicable Competitor and (B) not a significant competitor of the MSCI Business or reasonably anticipated to become a significant competitor of the MSCI Business, as determined in good faith by the Committee or (ii) any other business or activity of the applicable Competitor that is not a Competing Business.
“Permitted Services” means employment, engagement or the provision of assistance or services that (i) are solely administrative in nature, (ii) do not include any aspect of the operation, strategy, supervision, compliance or regulation of any Competing Business (including, without limitation, assistance or services relating to information technology, data, operations, product management, research, client coverage and support, compensation, recruiting, and marketing assistance and management) and (iii) with respect to any assistance or services to, or in support of, a Competing Business, are an immaterial portion of your overall job responsibilities to the applicable Competitor.
Ninth Floor | Ten Bishops Square | London, E1 6EG | United Kingdom
Office: +44 20 7618 2000 | F +44 20 7618 2233
MSCI Limited. Registered in England and Wales. Company Number: 03981254.
msci.com
Exhibit 31.1
SECTION 302 CERTIFICATION
I, Henry A. Fernandez, certify that:
1. |
I have reviewed this Quarterly Report on Form 10-Q of MSCI Inc.; |
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. |
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
(b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
(c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
(d) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. |
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: April 28, 2021
|
/s/ Henry A. Fernandez |
|
Henry A. Fernandez |
|
Chairman and Chief Executive Officer |
|
(Principal Executive Officer) |
Exhibit 31.2
SECTION 302 CERTIFICATION
I, Andrew C. Wiechmann, certify that:
1. |
I have reviewed this Quarterly Report on Form 10-Q of MSCI Inc.; |
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. |
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
(b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
(c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
(d) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. |
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: April 28, 2021
|
/s/ Andrew C. Wiechmann |
|
Andrew C. Wiechmann |
|
Chief Financial Officer |
|
(Principal Financial Officer) |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Henry A. Fernandez, Chairman and Chief Executive Officer of MSCI Inc. (the “Registrant”) and Andrew C. Wiechmann, Chief Financial Officer of the Registrant, each hereby certifies that, to the best of his/her knowledge:
1. |
The Registrant’s Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the “Periodic Report”), to which this Certification is attached as Exhibit 32.1, fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and |
2. |
The information contained in the Periodic Report fairly presents, in all material respects, the financial condition of the Registrant at the end of the period covered by the Periodic Report and results of operations of the Registrant for the periods covered by the Periodic Report. |
Date: April 28, 2021
/s/ Henry A. Fernandez |
|
/s/ Andrew C. Wiechmann |
Henry A. Fernandez Chairman and Chief Executive Officer (Principal Executive Officer) |
|
Andrew C. Wiechmann Chief Financial Officer (Principal Financial Officer) |